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Atrial fibrillation (AF), the most common cardiac arrhythmia, is 
characterized by disorganized electrical activities that cause atrial quivering and 
uncoordinated contraction. AF significantly affects the quality of life for patients 
and increases the risk of stroke. Ultrasound ablation surgery has been proposed a 
decade ago as a treatment for AF. By focusing ultrasound energy at a narrow 
spot, rapid temperature rises along with tissue necrosis are generated. In this 
thesis, we investigated high-intensity focused ultrasound (HIFU), an ablation 
technology being used to eliminate arrhythmogenic foci for treatment of AF. 
During HIFU ablation, little is known regarding the detailed 
characteristics of cellular electrophysiological (EP) changes. The first part of the 
thesis aims to characterize EP changes during HIFU corresponding with 
temperature increases. Langendorff-perfused intact rabbit heart model stained 
with di-4-ANEPPS, a fluorescent dye sensitive to the membrane voltage changes, 
was used. Simultaneous optical mapping and infrared imaging were employed 
to measure epicardial EP and temperature during HIFU application. The results 
revealed the temperature-dependent spatiotemporal characteristics of HIFU-
induced EP changes including changes of action potential (AP) amplitude, 
duration, and electrical activation. Temperature dosage criterion for generating 
irreversible tissue physical and AP changes were obtained.  
Intra-procedural imaging is important for guiding cardiac ablation for AF. 
However, it is difficult to obtain intra-procedural correlation of thermal lesion 
xviii 
 
with AP changes in tissue transmural plane. The second part is to develop 
parametric ultrasound imaging techniques for transmural lesion and AP 
detection during ablation. Perfused canine ventricular wedge was used. 
Simultaneous optical mapping and high frequency ultrasound imaging of the 
same tissue trasnsmural plane were performed during HIFU. Tissue transmural 
EP changes were characterized and the AP changes were spatiotemporally 
correlated between optical and ultrasound images. The results show that 
parametric ultrasound imaging using cumulative extrema of ultrasound 
parameters (log-normal and Rayleigh) can detect HIFU lesions and surrounding 
AP amplitude changes. 
Overall, the information obtained from this thesis enhances our understanding of 
the EP mechanisms of HIFU ablation and can help promote the development of 
effective HIFU ablation strategies. Ultrasound parametric imaging provides a 
promising technique to identify lesion transmurality which is important in 





CHAPTER 1  
Introduction 
The objective of this dissertation is to investigate the thermal effect of 
high-intensity focused ultrasound (HIFU) in changing cellular electrophysiology 
(EP) of cardiac tissue. The research primarily focuses on two different aspects: 
characterization of EP properties and their correlations with temperature 
changes during HIFU ablation, and the development of imaging technology to 
monitor HIFU induced tissue physical and EP changes. The detailed information 
of EP and histopathological responses upon HIFU and the imaging feedback 
scheme can help improve the safety and efficacy of current HIFU techniques in 
clinical cardiac ablations. 
 
1.1 Atrial Fibrillation 
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, 
characterized by abnormal or unsynchronized supraventricular electrical 
activities.1 An estimate of 2.2 million adults in U.S. have been affected by AF, and 
the prevalence of AF, increasing with ages, has kept growing by 160,000 
annually.2 Patients with AF often complain of palpitations, weakness, fatigue, 
2 
 
chest pain, and impaired exercise tolerance. The long-term risks of stroke, heart 
failure and all-cause mortality increase substantially for AF patients3. 
 
Figure 1.1 Illustration of the electrical system for a normal heart (top left) and an atrial 
fibrillation (AF) heart (top right). Corresponding electrocardiogram (ECG) for the 
normal heart (bottom left) shows regular R-R interval and apparent P waves, and for the 
AF heart shows irregular R-R intervals and no discernible P waves. Copyright © 2008 
Atrial Fibrillation Teaching File, Department of Medicine, University of Toronto. 
During normal sinus rhythm, the electrical activity (typically, 50 – 80 bpm 
at rest) is initiated by the sinoatrial (SA) node, the natural pacemaker in the high 
right atrium. This is followed by organized electrical activation across both atria, 
generating mechanical contraction, which propels blood into the corresponding 
ventricular chambers after a physiologic delay at the atrioventricular (AV) node. 
During AF, the electrical activity in the atria is seemingly uncoordinated with 
activation rates exceeding 400 bpm. Although the conduction decremented at the 
AV node, among other factors, prevents transmission of rapid rates into the 
3 
 
ventricles, the pulse rate may approach 180 bpm as compared to the normal rate 
of 60 – 80 bpm at rest. During AF, localized reentrant activity or rapid focal 
discharge are assumed to be responsible for driving the fibrillatory process.4 And 
the SA node is of course overdriven by their rapid activity. Mechanically, there is 
no longer coordinated mechanical atrial activity, and AV synchrony is lost. This 
leads to diminution of cardiac output responsible for various symptoms during 
AF. Figure 1.1 shows the electrical sequences of a normal heart and an AF heart. 
On the surface electrocardiogram (ECG) recording, AF is characterized by 
rapid, low-amplitude and pleomorphic “f” waves and irregular R-R intervals5 
(Figure 1.1). AF may be classified into three categories: paroxysmal AF, 
persistent AF, and longstanding persistent AF6, and they are not mutually 
exclusive. In paroxysmal AF, multiple AF episodes occur but terminate 
spontaneously within less than a week, typically lasting for several hours. 
Persistent AF refers to AF episodes which last for more than 7 days or those 
require pharmacologic or electrical cardioversion. Longstanding persistent AF is 
defined when AF is continuous for more than one year.7 These classifications are 
prognostically important in that patients with paroxysmal AF tend to have less 
structural remodeling and are more likely to respond to catheter ablation as 
opposed to patients with longstanding persistent AF who demonstrate much 
more structural abnormalities and are less likely to respond to ablation. In a 
recent worldwide survey from 9816 AF patients who had at least 1 AF episode in 
the last 12 months or current documented AF, with roughly 30 % of them 
received at least 1 admission of hospitalization and 90 % of them received 
antiarrhythmic drugs, 26.5 % had paroxysmal AF, 23.8 % had persistent AF, and 
49.6 % had longstanding persistent AF.8 As the burden of AF episodes increases, 
the risks of thrombus (“blood clot”) formation also increase, leading to increased 
occurrence of stroke. It has been shown that the stroke incidence can increase 
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more than fivefold when AF is presented.9 Epidemiology studies suggested that 
AF and heart failure often co-exist and the prevalence of AF in heart failure 
patients can exacerbate the severity of the disease.10,11 Therefore, timely treatment 
of AF becomes critically important. 
 
1.2 Treatment of Atrial Fibrillation 
Generally, patients with AF can be treated through two approaches, rate 
control and rhythm control, depending on the severity of AF.12 Rate control is 
achieved by slowing the ventricular rate to allow sufficient time for blood filling 
into ventricles. After rate control therapy, patients with AF suffer fewer 
symptoms but irregular heart rhythm still persists. The goal in rhythm control is 
to restore to its normal sinus rhythm, which helps restore AV synchrony and 
eliminate the rapid and irregular pulse rate. Rhythm control is preferable but 
may be challenging to achieve for various reasons. Under either approach, 
anticoagulant medications are recommended to prevent clot formation and 
reduce the risks of stroke.13 
Heart rate control can be achieved pharmacologically or by targeted 
destruction of the AV node by catheter ablation.14 The latter requires 
simultaneous implantation of a permanent pacemaker since AV node ablation 
renders the patients pacemaker dependent. Rate-controlling agents, including 
beta blockers, nondihydropyridine calcium channel antagonists, digoxin, and 
others, which prolong the refractory period of AV node, and are effective in most 
patients in achieving rate control.15-17 However, bradycardia and AV block may 
develop in some patients.18 When pharmacotherapy fails, AV nodal ablation 
combined with pacemaker implantation is an option for patients who are not 
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considered to be good candidates for a sinus rhythm strategy such as the elderly 
or those with multiple comorbidities. A meta-analysis demonstrated significant 
improvement of quality of life, ventricular function, exercise tolerance and 
reduced AF symptoms as well as healthcare for AF patients who received 
ablation and pacing therapy.19 However, lifelong anticoagulation and pacemaker 
dependence, with its attendant complications, are important considerations. 
Patients chosen for a thythm strategy are treated with antiarrhythmic 
medications. Pharmacotherapy has been very effective when AF lasts less than 48 
hours, but with a significant decrease in conversion rate when duration of AF is 
beyond 48 hours.13 Antiarrhythmic drugs such as flecainide, propafenone, 
sotalol, amiodarone, and dofetilide are options for daily suppressive therapy 
depending on the patient’s clinical age and status.20-24 However, the overall 
antiarrhythmic efficacy is modest.25 The other limitation is their proclivity to 
prolong ventricular repolarization or slow conduction velocity, which may result 
in ventricular tachycardia or fibrillation, and lead to adverse clinical outcomes, 
including death. Amiodarone, for example, although probably the safest with 
respect to proarrhythmia, may result in end organ toxicity such as pulmonary 
fibrosis and may increase mortality rates. 
Pharmacotherapy is often inadequate to achieve and maintain normal 
sinus rhythm especially for patients with persistent AF. Transthoracic direct-
current (DC) electrical cardioversion is extremely effective in restoring sinus 
rhythm and allows for introduction of the aforementioned antiarrhythmic 
medications to decrease the likelihood of recurrence.26 However, at one year 
follow-up, 63 % of patients had relapsed AF27 which again speaks to the modest 
effectiveness of medical therapy for AF28,29. 
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Given the limitations of medical therapy, interventional approaches were 
sought in an effort to more definitively eliminate AF. To this end, Cox and 
colleagues pioneered a surgical ablation procedure, called the Maze procedure, 
in the early 1990s.30 In this procedure, a series of incisions and sutures are made 
at strategic locations in the atria. Simultaneously, the left atrial appendage, the 
major source of thromboemboli, was ligated, which was associated with a 
significant decrease in stroke at long-term follow up. During initial clinical 
practices, approximately 90 % of AF patients were rendered arrhythmia free.31 As 
the technique evolved, Cox maze III procedure has become the gold-standard for 
patients undergoing catheter or surgical ablation of AF.32 However, the 
procedure usually requires open-heart surgery, cardiopulmonary bypass, which 
greatly limits its widespread use in patients who otherwise may not have other 
indications for cardiac surgery. The invasiveness and the complexity of the cut-
and-sew maze procedure has ushered the age of minimally invasive arrhythmia 
which attempts to mimic the clinical results of the classic procedure via small 
incisions or thorascopitcally. However, the results of minimally invasive 
arrhythmia surgery on the beating heart do not approach those of the cut-and-
sew maze.33 
 
1.3 Current Ablation Techniques 
The invasiveness and morbidity of the surgical approach spurred the age 
of catheter ablation. The original catheter-based approach attempted to mimic 
surgical lesions place during maze procedure. This procedure, pioneered by Dr. 
Swartz34, was associated with modest success rates by today’s standards but was 
abandoned due to the relatively high rates of complications. 
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The development of current ablation techniques stem from better 
understanding of the mechanisms of the initiation and perpetuation of AF. Two 
major theories, multiple wavelet hypothesis and localized trigger and/or reentry 
hypothesis, were proposed. Moe and colleagues conceptualized AF as being due 
to multiple randomly meandering wavelets.35 Clinically, paroxysmal AF has been 
shown to be triggered and perhaps maintained ectopic reentry in the pulmonary 
veins (PV) located in the posterior left atrium. Haissaguerre et al. showed in 1998 
that these focal discharges may be eliminated by catheter ablation within the 
PVs, leading to improved outcomes in patients who had not responded to 
medical therapy.36 The atria are connected to the PV via myocardial sleeves 
which are electrically disconnected during a PV isolation procedure. Histological 
examination of the PV-LA junction shows evidence of anisotropy which may 
serve as a substrate for reentry. Other triggers were proposed to be originating at 
ganglionic plexus and axons, vein and ligament of Marshall, and superior and 
inferior vena cava, and are shown in Figure 1.2.36-40 Focal activity can generate 
high frequency reentrant wavelets (rotors) which further fragment into daughter 
rotors as they propagate across heterogeneous atrial substrates, and maintain 
fibrillatory atria.41,42 To ablate these focal discharges, several currently available 




Figure 1.2 Mechanisms of initiation and perpetuation of AF. Focal foci generated from 
ganglionic plexus (yellow), junction of pulmonary veins and left atrium (red stars), vein 
of Marshall (blue), and others (green). Large and small reentrant wavelets can sustain 
AF. LSPV/RSPV = left/right superior pulmonary vein; LIPV/RIPV = left/right inferior 
pulmonary vein; SVC/IVC = superior/inferior vena cava. (Copyright © Heart Rhythm43) 
1.3.1 Radiofrequency Ablation (RFA) 
Radiofrequency ablation (RFA) is achieved by applying alternating 
electrical current within the frequency range of 100 – 1000 kHz on myocardial 
tissue, which acts as a resistive medium. Tissue resistivity turns the electrical RF 
energy into heat, which is then absorbed by myocardial tissue and dissipated 
passively along the radial direction to surrounding tissue layers. When tissue 
temperature reaches 50 °C or higher for certain duration (usually 60 – 90 seconds 
for RF ablation), tissue necrosis occurs and becomes non-conductive.44 RF energy 
is the first approved energy source for cardiac ablation by U.S. Food and Drug 
Administration (FDA). Over the past two decades, catheter-based RFA has been 
the cornerstone for treating different types of arrhythmias including AF. 
Comparing with antiarrhythmic pharmacotherapy, PVI using RFA greatly 
reduced the recurrence of AF and improved the quality of life of AF patients.20 In 
a recent report, 79.5 % patients with paroxysmal AF restored sinus rhythm after 
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receiving 1 – 3 PVI using RF ablation at a 4.6 years follow up.45 However, the 
success rate after PVI via RFA for patients with persistent AF remains low.46 
Significant complications were observed during RF ablation of AF including PV 
stenosis, thromboembolism, phrenic nerve injury, and possibly life-threatening 
esophagus injury.47-51 These limitations compounded by poor monitoring ability 
increase the chance for procedural failure. In addition, PVI using RFA is often 
performed in a point-by-point ablation fashion which significantly prolongs the 
operation during (e.g. > 100 min)52. 
1.3.2 Cryoablation 
Cryoablation is another FDA approved energy source for treating AF. 
During cryoablation, liquid nitrogen or compressed argon gas undergoes phase 
transition (liquid to gas) which significantly decreases the surrounding 
temperature. Typically, two different modes are performed during cryoablation: 
temperature ≥ – 30 °C (duration ≤ 80 seconds) for pre-ablation cryomapping and 
temperature ≤ – 68 °C (duration up to 4 mins) for cryoablation to generate 
complete irreversible tissue damage.53 Therefore, average procedural time using 
cryoablation is lengthy (206 mins); however, procedural times do improve with 
experience.54 Seventy three percent of the patients with paroxysmal AF were free 
from AF at 1-year follow up,54 comparable to RF ablation55. Fewer complications 
were seen under cryoablation with the major complication being phrenic nerve 
paralysis while majority patients recovered completely 12 months after the 
procedure.56 Although no atrioesophageal fistula (AEF) was observed during the 
early cryoablation experience54, more recent data with the larger 28 mm balloon 




1.3.3 High Intensity Focused Ultrasound (HIFU) 
With the unique capability of inducing intramural ablations at various 
depths without damaging intervening tissue, high-intensity focused ultrasound 
(HIFU) ablation has been widely used to treat different diseases especially for 
tumors (e.g. prostate cancer, breast cancer).58,59 As high frequency acoustic wave 
propagate across tissue, tissue medium absorbs the acoustic energy and 
dissipates it as heat. Using electrical focusing or acoustical lens technique, 
ultrasound energy can be concentrated at a narrow spot (> 500 W/cm2), where 
rapid temperature rises (up to 80 °C within seconds60) and tissue modifications 
(e.g. protein denaturation, tissue coagulation, and necrosis) are generated within 
confined volume without direct tissue-probe contact.  
HIFU ablation has been successfully tested both in vitro and in vivo on 
cardiac tissue such as AV node, PVI, ventricular septum, and mitral valve.61-64 
Positive results have been reported of using HIFU energy for treating AF.65,66 
Multicenter trails involving 5 European centers reported 85 % of patients with 
paroxysmal AF were free from AF at six-month follow up using a HIFU balloon 
system for PVI.66 Despite the initial success, the clinical application of HIFU 
ablation in treating AF is significantly limited due to incomplete understanding 
of physiological mechanism of HIFU energy deposition in the heart. Severe 
complications including pulmonary embolism, phrenic nerve damage, AEF, and 
even mortality occurred at a relatively high rate comparing to RFA and 
cryoablation,67-70 leading to HIFU technology being withdrawn from the market. 
Unlike RFA and cryoablation, HIFU technique in ablation of AF is 
relatively new. In ultrasound surgery, tissue changes are generally achieved 
through two different mechanisms: thermal effect mainly due to tissue 
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absorption (HIFU) and mechanical effect induced by acoustic cavitation (e.g. 
histotripsy71), whereas thermal effect is more desirable for ablation of AF. The 
development of HIFU technology mainly focused on the correlation between 
HIFU parameters (e.g. acoustic power, duration) and the sizes of HIFU 
lesions.72,73 “Surrogate” parameters such as tissue temperature and thermal dose 
were also used to monitor HIFU ablation and predict lesion formation.74,75 
However, whether HIFU-induced tissue necrosis shows comparable EP changes 
as RF or cryoablation lesions is unknown. The relationship between HIFU lesions 
and regional EP property changes has not yet been characterized. The missing 
knowledge can be beneficial to understand the mechanisms of HIFU ablation on 
changing cardiac EP and to develop safer and more effective HIFU metrics for 
generating sustained cardiac EP changes in treating AF.  
 
1.4 Dissertation Outline 
This dissertation consists five chapters. In CHAPTER 1, an overall 
background of atrial fibrillation (AF), treatment methods for AF and ablation 
techniques including HIFU are reviewed with a brief description of the general 
motivation in the end. In CHAPTER 2, the technique of using optical mapping to 
monitor HIFU ablation in Langendorff-perfused intact rabbit heart is presented. 
HIFU generated cellular electrophysiological (EP) changes are qualitatively 
investigated. In CHAPTER 3, HIFU induced EP changes are quantitatively 
characterized using the methodology described in the previous chapter, and the 
corresponding EP changes are correlated spatiotemporally with HIFU induced 
tissue temperature rise. Temperature criterions for generating reversible and 
irreversible tissue physical and EP changes are found in the end. CHAPTER 4 
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presents the correlation between HIFU generated lesion and EP changes along 
the tissue depth direction. Ultrasound parametric imaging techniques are 
developed to image the HIFU lesions and surrounding irreversible action 
potential changes. Finally, conclusions of this work and several suggestions 
regarding future study are summarized in CHAPTER 5. 
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CHAPTER 2  
Optical Mapping of Intact Heart 
during HIFU 
In this chapter, the feasibility of using optical mapping, which has been 
used extensively in EP experimental laboratories, to measure EP changes during 
HIFU ablation in real time is tested. Since EP parameters cannot be measured in 
in vitro non-perfused tissue specimens, a Langendorff-perfused intact rabbit 
heart model is employed for the ablation and the detailed methodology of the 
heart preparation is described. A method of processing optical mapping data is 
standardized for the rest chapters. HIFU induced EP changes are qualitatively 
investigated along with tissue histopathological changes. Finally, a real-time 
mapping-ablation system is established and the results provide useful tissue 
electrophysiological information about HIFU cardiac ablation. 
 
2.1 Overview 
Cellular electrophysiological and tissue histopathological changes have 
been well documented for RF ablation using either microelectrodes or optical 
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mapping techniques.1-4 These results provided important knowledge for 
understanding the mechanism of RF ablation and advanced the technology in 
cardiac ablation. Compare to RF technique, although the feasibility of HIFU 
application in cardiac ablation has been demonstrated experimentally5-8, much 
work needs to be done to successfully translate the technology into clinical 
practice. While most researches of HIFU ablation focused on determining the 
correlation between lesion volumes with HIFU parameters9,10, few studies have 
elucidated the HIFU thermal effects on cellular electrophysiology during and 
after HIFU ablation. 
Optical mapping and development of fast fluorescent voltage-sensitive 
dyes (VSD) have significantly enriched the research in cardiac EP field. By using 
VSD, cellular transmembrane action potentials can be measured at high 
spatiotemporal resolution non-invasively which was not possible and 
inconvenient using conventional electrodes.11 This advanced technique allows us 
to measure cardiac EP changes remotely in real time without interfering the 
HIFU acoustic field during HIFU ablation, therefore, providing useful 
methodology to study HIFU ablation. Evidences of HIFU generated cardiac EP 
modifications can be acquired directly and enhance our understanding about 
HIFU effects on cellular EP as well as help us optimize HIFU cardiac ablation. 
Compare to previous HIFU studies using in vitro tissue, the Langendorff-
perfused rabbit heart provides the physiological and EP properties more relevant 
to in vivo heart condition. For example, as most experimental studies of HIFU 
have been performed in degassed saline, the oxygenated Tyrode’s solution in 
Langendorff system replicates the gaseous condition in human body. The 
increased gas nucleus may increase the risk of HIFU related cavitation. The 
constant perfusion in Langendorff system acts similar as blood cooling which 
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may be beneficial to study HIFU effect in in vivo condition. Furthermore, the EP 
characteristics derived from rabbit hearts can be proportionally scaled and 
extrapolated into human hearts. 
 
2.2 Method 
2.2.1 Langendorff-perfused Intact Rabbit Heart Preparation 
Five New Zealand white rabbits (either sex, 2 – 3 kg) were used in this 
study according to a protocol approved by the University Committee on the Use 
and Care of Animals (UCUCA) at University of Michigan. The rabbits were 
anesthetized by intramuscular injection of ketamine (35 mg/kg) and xylanzine (5 
mg/kg). Heparin (1000 Unit/kg) was administered through a marginal ear vein to 
prevent blood clotting and the rabbit was euthanized by bolus injection of 
sodium pentobarbital (100 mg/kg). Each heart was harvested by median 
sternotomy and rapidly transported to a Langendorff perfusion system using 
warm Tyrode’s solution12 (128.2 mM NaCl, 1.3 mM CaCl2, 4.7 mM KCl, 1.19 mM 
NaH2PO4, 1.05 mM MgCl2, 20.0 mM NaHCO3, and 11.1 mM glucose). Details of 
solution preparation are described in APPENDIX. The isolated heart was then 
quickly placed in the Langendorff apparatus and peripheral tissues (e.g. thyroid, 
trachea) were trimmed off while the heart was retrogradely perfused with 
oxygenated Tyrode’s solution (pH = 7.35 ± 0.05; 37 °C; 95 % O2/5 % CO2) via aorta 
at constant pressure of 60 – 80 mmHg.13 After tissue cleaning, the heart was 
mounted on a tissue holder (Figure 2.1) and bathed in the same Tyrode’s solution 
within the temperature range of 35 – 37 °C for superfusion. Excitation-
contraction decoupler, 2,3-butanedione monoxime (BDM, 15 mM, Fisher 
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Scientific, Fair Lawn, NJ, USA) was used in both perfusion and superfusion 
solution to suppress motion artifacts during whole heart optical mapping due to 
heart contraction. To prevent motion induced by fluid streaming and maximize 
heart surface for optical mapping, the heart was pushed gently between two 
acoustic transparent (polycarbonate film) screens. 
 
Figure 2.1 Tissue holder and experiment setup. (A) CAD of the heart holder used to 
stabilize the heart and reduce motion artifact. Acoustic transparent screens are 
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positioned in the front and the back to clamp the heart. (B) CAD of the experimental 
setup. Optical mapping and HIFU ablation are co-axial aligned from the same direction. 
The transducer is a ring shape with a round window in the center allowing 
simultaneous optical mapping. (C) Photograph of the experimental setup. 
The electrocardiogram (ECG) was monitored via two floating needle 
electrodes. The ECG signals were filtered (0.5 – 50 Hz), amplified, and recorded 
via a digitizer (PowerLab 26T, ADInstruments, Colorado Springs, CO, USA). 
Aortic perfusion pressure was also monitored by a pressure transducer (BLPR2, 
World Precision Instruments, Sarasota, FL, USA). The ECG, aortic pressure, 
perfusion temperature, and pH value were monitored continuously throughout 
entire experimentation to ensure physiological stability of the heart. The heart 
typically remained healthy for 3 – 4 hours while experimentation was completed 
within the first 1.5 hours. 
2.2.2 HIFU Ablation System 
The HIFU transducer (H-148, Sonic Concepts, Bothell, WA, USA) was a 
ring-shaped single element transducer with a geometrical focal length of 63.2 
mm, F-number of 0.98, and a center frequency of 2.0 MHz. It was fixed at the side 
of the superfusion tank with its focus placed at the proximal sub-epicardium of 
the heart. The HIFU transducer was driven by a signal generator (33250A, 
Agilent Technologies, Palo Alto, CA, USA) and a power amplifier (75A250, 
Amplifier Research, Souderton, PA, USA). Electrical power output was 
monitored by a power meter (PM-1, JJ&A Instruments, Duvall, WA, USA). 
The acoustic field of the HIFU transducer was measured using a custom 
fiber optic probe hydrophone (FOPH) system with active element size of 125 
μm.14 The output of FOPH was digitized by an oscilloscope (Infiniium 54830B, 
Agilent Technologies, Palo Alto, CA, USA) and transferred to a PC for offline 
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pressure analysis. A deconvolution algorithm was employed to reduce system 
error. Based on the measured pressure waveforms (Figure 2.2), HIFU 6-dB beam 
size was confirmed to be 0.9 mm in the lateral direction and 7.2 mm in axial 
direction. The focal intensities (Isppa: spatial-peak pulse-average) were measured 
between 700 and 4000 W/cm2 with approximately 10 % uncertainty. 
 
Figure 2.2 Pressure waveforms of HIFU pulses at the focus of the transducer with and 
without waveform deconvolution (left). Transverse two-dimensional acoustic beam of 
the transducer for the peak positive (top right) and peak negative (bottom right) 
pressure with waveform deconvolution. 
 
2.2.3 Mapping-Ablation Procedure 
Fifteen minutes after ECG signal stabilized (periodic R-wave intervals), 
the heart was stained with a fluorescent voltage-sensitive dye (VSD) di-4-
ANEPPS (Invitrogen, Carlsbad, CA, USA) at 10 μM concentrations by bolus 
injection into the perfusate for 10 – 15 mins. Excitation light was generated by 
two green-filtered light-emitting diodes (531 ± 45 nm, 5G Illumination, SciMedia 
USA Ltd., Costa Mesa, CA, USA). The emitted fluorescence was long-pass 
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filtered (> 630 nm) and detected by a high-speed CMOS camera system (MiCAM 
Ultima-L, SciMedia USA Ltd., Costa Mesa, CA, USA) at a frame rate of 1000 
frames/s and spatial resolution roughly 420 − 460 μm/pixel (100 × 100 pixels). 
Entire optical mapping was performed in a dark room. 
Optical mapping was synchronized with the HIFU pulses via a custom-
designed field-programmable gate-array board (FPGA) (Cyclone® II, Altera 
Corp., San Jose, CA, USA), which first triggered optical CMOS camera for 4 s 
baseline recording and followed by triggering 10 s continuous-wave HIFU 
exposure. To maximize the signal-noise-ratio for the optical mapping, the 
excitation light intensity was adjusted before data acquisition by setting the 
highest pixel intensity to be about 80 % of the saturation value estimated over 
several cardiac cycles. In order to generate lesion on a perfused heart, the 
intensity of the HIFU was set relatively higher at 3000 W/cm2 (Figure 2.2) 
(typically > 1000 W/cm2 for in vitro experiments) in a 10 s tone-burst mode. 
Optical mapping recorded optical action potentials (OAPs) in real time 
continuously for 32 s. 
After each experiment, the heart was photographed and followed by 
triphenyltetrazolium (TTC, Sigma Aldrich, St. Louis, MO, USA) staining, where 
tissue necrosis was stained as white/yellow and viable tissue was stained as dark 
red. Details of performing TTC staining are described in APPENDIX. The TTC 
stained heart was photographed again and HIFU lesion area was chopped and 
stored in 10 % formalin for > 48 hours. The lesion section was then paraffin 
embedded, and sectioned with 100 μm step size across the lesion mid-line. 
Masson’s trichrome (MT) staining was performed and the stained slides were 
scanned with a scanner (CanoScan 8800F, Canon USA, Inc., Melville, NY, USA) 
and imaged again under microscope. 
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2.2.4 Data Analysis of Optical Mapping Data 
Optical mapping recorded signals were analyzed using customed Matlab 
algorithms (v. 2011b, Mathworks, Natick, MA, USA) as described in literature15. 
Spatial averaging (3 × 3) and a band-pass (0 – 100 Hz) FIR filter were applied for 
spatiotemporal smoothing of the VSD images. The effects of photo-bleaching 
were corrected via exponential fitting ( lg( )Y b a X   , where coefficients a and b 
were derived from pre-HIFU baseline values) of the VSD baseline values prior to 
HIFU application. Optical action potentials (OAPs) were normalized from 0 to 
unity and AP amplitude (APA) was defined as the value between OAPs peak 
and the resting potential. Activation time was identified as the corresponding 
times when ( ) /d F dt  reached maximum in an individual cardiac cycle, where
F , or the fractional fluorescence change, was the ratio between the change of 
fluorescence signal intensity and the background fluorescence level. Activation 
maps were formed from the activation time at each pixel and conduction 
velocities (CVs) were derived as the spatial gradient of the activation map. AP 
duration at 50 % and 80% of repolarization (APD50 and APD80) were defined as 
the duration between activation time and 50% or 80 % peak APA value at 
repolarization. Changes in APA (∆APA), APD50 (∆APD50), APD80 (∆APD80), and 
activation times (∆activation) were calculated by subtracting the pre-HIFU 
baseline values. Graphical representations of optical mapping data processing 




Figure 2.3 Optical mapping data processing procedure. (A) Diagram of optical mapping 
acquisition procedure. (B) Optical mapping images were first thresholded based on 
grayscale intensity and VSD mask was generated. (C) After thresholding, image was 
smoothed using 3 × 3 binning algorithm and filtered using FIR filter. Representative 
OAP at labeled pixel are shown at raw and after smoothing and filtering. OAP signal 
was then divided by optical mapping background image to generate fractional 
fluorescent signal (∆F) and baseline offset was corrected. (D) APA map was generated 
from baseline corrected ∆F signal and first derivative of ∆F was calculated and the 
corresponding time index was the activation time and amplitude is the OAP upstroke 
velocity ([d(∆F)/dt]max). APA map was normalized to the maximum pixel and APD50 and 
APD80 were found as shown. (E) Representative maps of APD50, APD80, activation, and 




Figure 2.4 Generation of conduction velocities (CVs) map from activation map. CVs map 
are generated by taking the spatial gradient of activation map. The amplitude and 
direction of CVs are represented by the direction and length of red arrows. 
 
2.3 Optical Mapping of HIFU Ablation 
2.3.1 HIFU induced Tissue Physical Changes 
During HIFU ablation, dramatic tissue histopathological changes were 
observed. In the ablation cases (n = 5), HIFU transducer was aligned such that its 
focus was placed at the epicardium of the heart. Post HIFU gross tissue 
examination demonstrated necrotic spot (~ 1 mm in diameter) in the epicardium 
with apparent discoloration (Figure 2.5). On the TTC stained images, HIFU 
lesions in the intact heart were clearly demarcated with a diameter covering 1.2 – 
2.3 mm and maximal axial depth up to 4.2 mm for 10 s tone-burst HIFU 
applications. 
Masson’s trichrome histology further confirmed HIFU generated tissue 
damage. Lesion regions were stained as purple, indicating a hypereosinophilic 
reaction, while normal tissue was stained as pink (Figure 2.5). Clear contraction 
band condensation and a rim of inflammatory cells were seen at the edge of the 
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HIFU lesions. Within the lesions, disrupted myofibrils and cell derangements 
were observed while normal tissue area showed intact cell structure and tight 
cell-cell connections, suggesting a minimum collateral damage outside HIFU 
focal area. 
 
Figure 2.5 Example of gross image and masson’s trichrome (MT) staining of HIFU 
generated lesion. Photograph of gross tissue with lesion (left) and MT slides at different 
cutting sections (0, 300, 600 μm) (right) are shown. 
 
2.3.2 Effect of HIFU on Action Potential 
Along with tissue physical changes, HIFU also induced significant action 
potential (AP) morphological changes. In the example shown in Figure 2.6, HIFU 
generated AP amplitude changes were up to 34 % compared to control area (< 2 
%). Both APD50 and APD80 within the HIFU focus were greatly shortened by 36 % 
and 26 % respectively. Upstroke velocities of APs ( max[ ( ) / ]d F dt  ) were also 
reduced by up to 52 %. Area with ∆APA and upstroke velocities reductions 
appears to be more localized than the areas with APD changes. APD50 showed 
severer shortening than APD80, suggesting great AP triangulations which can be 
indicative of electrical conduction diminishment. Temporal trace of ∆APA and 
upstroke velocity in the center of the lesion was irreversible after HIFU ablation. 
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Residual damages on APD50 and APD80 were observed after HIFU ablation and 
followed by gradual recoveries which were incomplete at the end of the 32 s 
optical recording. 
 
Figure 2.6 Example of HIFU induced action potential changes. Temporal development of 
two-dimensional (A) ∆APA, (B) ∆APD50, (C) ∆APD80, and (D) upstroke velocity of AP (
max[ ( ) / ]d F dt  ) before (< 4 s), during (4 s – 14 s), and after (15 s – 32 s) HIFU ablation. 
All AP parameters were normalized to pre-HIFU status. (E) Temporal traces of 
corresponding AP parameters within the center the HIFU lesion and in the normal tissue 
(control). 
 
2.3.3 Effect of HIFU on Electrical Conduction 
HIFU also generated electrical conduction changes as shown in Figure 2.7. 
In our experiments, all hearts were under sinus rhythm. Prior HIFU ablations, 
organized activation patterns across the ventricular epicardium were seen. After 
applying HIFU energy, distortions of activation isochrones were detected at the 
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HIFU focal area. As electrical wavefronts approached the HIFU lesions, 
significant bifurcation and clustering of isochrones occurred at the front edge of 
the lesions along with local activation delay within and behind lesion areas. 
Activation time was delayed by up to 6 ms within the lesion area. Conduction 
velocities (CVs) also changed dramatically around the HIFU lesions. In Figure 
2.7C, after lesion formed, CVs tended to propagate around the lesion with CVs 
amplitudes reduction in the front edge (right side in the ROIs of Figure 2.7C) of 
the lesion but amplitudes increases surrounding and in the rear of the lesion 
(bottom left corner in the ROIs of Figure 2.7C). However, after the cessation of 
HIFU application, we did not see a complete conduction block when single 
lesion was generated. Several reasons such as smaller lesion sizes, optical “bleed-
over” from adjacent pixels during recording, and electrical propagation around 
and under the lesion combined may cause the conduction delay being non-
sustained. 
 
Figure 2.7 Example of HIFU generated electrical conduction changes. Two dimensional 
temporal changes of (A) activation time, (B) activation delay, (C) conduction velocities 
(CVs) changes at the same time in Figure 2.6. In the CVs maps, the amplitudes and 
directions of CVs are represented by the lengths and directions of the red arrows. The 




In this proof-of-concept study, we directly observed HIFU generated 
cardiac electrophysiological changes including APA reduction, APD shortening, 
AP upstroke velocity decrease, and distortion of activation patterns using optical 
mapping technique. Although optical mapping provided new methodology to 
study HIFU ablation, several cautions much be taken when using this technique. 
The optical signal recorded at each pixel on the CMOS sensor is a 
weighted summation of emitted fluorescence from a volume of cells rather than a 
single cell. The imaging depth depends on the excitation and emission spectral 
properties of the fluorescent VSD. VSD has longer emission wavelength tends to 
provide more information about deeper tissue layers. For di-4-ANEPPS, majority 
of the detected signals from epicardial surface emanates from a tissue depth less 
than 300 μm for a rabbit heart.16 Therefore, interpretation of the optical mapping 
signals needs to be done carefully, especially when HIFU generated lesions were 
beyond the imaging depth. It is unclear how much weight the subsurface HIFU 
lesion can contribute to reductions of the surface optical action potentials. Tissue 
absorption and photonic scattering may lead to miss interpretation about the 
epicardial optical mapping signals. Furthermore, the VSD used in our study has 
been demonstrated to cause photodynamic damage to isolated cardiomyocytes.17 
Although no significant photo-toxicity of the VSD was observed on isolated 
hearts, restricted excitation should be performed to reduce the risk of optical 
mapping related tissue damage. Another limitation of the optical mapping is 
cardiac repolarization related motion artifacts. It has been well noticed cardiac 
motion can deteriorate the optical mapping signals. In our study, excitation-
contraction decoupler (BDM), which has been proved to affect the 
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electrophysiological property (e.g. calcium channel kinetics) of the cardiac 
tissue18, was used. To avoid such side effect, a more appropriated decoupler 
blebbistatin, which showed no adverse effect on cellular EP19, should be used.  
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CHAPTER 3  
Electrophysiology Changes and 
Correlation with Temperature 
In this chapter, HIFU induced cellular electrophysiological (EP) changes 
are correlated with corresponding temperature increases. The same Langendorff-
perfused intact rabbit heart described in CHAPTER 2 was used. Simultaneous 
optical mapping and infrared imaging techniques were employed to measure 
epicardial EP and temperature during HIFU ablation. Since HIFU induced 
temperature changes have never been correlated with tissue EP before, the 
results can help us better understand the thermal effect of HIFU on cellular EP 
and provide thermal dosage information to guide HIFU cardiac ablation. 
  
3.1 Overview 
The technology of HIFU has been explored extensively. A number of in 
vitro studies have investigated the relationships between HIFU parameters (e.g. 
acoustic power, exposure time) and tissue necrosis.1,2 Temperature and thermal 
dose were often used as indicators for tissue ablation.3,4 However, these studies 
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have not elucidated HIFU induced cellular electrophysiological (EP) changes and 
their relationship with temperature increases. 
Nath et al. first studied the temperature effects on cardiac EP properties 
including resting membrane potential (RMP), action potential (AP) amplitude 
and duration, and cellular automaticity and excitability in hyperthermia5, and 
advanced the development of RF and microwave ablation. Haines further 
elucidated on the biophysics of RF ablation6 and Wu et al. demonstrated that RF 
energy had both electronic and thermal effects on changing cellular EP7. Wood et 
al. showed the long term effect of RF ablation on cellular EP changes.8 Whether 
EP changes during HIFU ablation are similar to RF ablation has not been directly 
confirmed. The detailed spatiotemporal information regarding cellular EP 
dynamics during HIFU ablation may help to improve current HIFU technique in 
cardiac ablation. 
As demonstrated in CHAPTER 2, HIFU induced cardiac action potential 
(AP) changes can be optically mapped using perfused intact heart preparations. 
In this study, by combining infrared (IR) imaging with optical mapping, we 
obtained for the first time the spatiotemporal correlated measurements of 
temperature and EP changes during HIFU ablation in order to investigate the 
detailed characteristics of HIFU induced EP changes and their correlation with 
temperature. As electrical conduction block is often the endpoint for cardiac 
ablation therapy, information about cellular EP changes during HIFU ablation 
may help improve our understanding of the mechanisms of HIFU cardiac 
ablation and develop strategies to reduce the risk of electrical reconduction and 





Isolated heart preparations are the same as described in CHAPTER 2. 
Eleven New Zealand white rabbits were used in this study following a protocol 
approved by UCUCA at University of Michigan. 
3.2.1 Simultaneous Optical Mapping and Infrared Imaging 
As shown in Figure 3.1, the heart preparation was placed in a custom-
made holder with an acoustically transparent window (Tegaderm Film, 3M Co., 
St. Paul, MN, USA) of the size 4.5 × 4.5 cm2 for ultrasound transmission from 
below. The heart was pinned from the apex, right, and left atrial appendages to a 
silicone gel pad (Sylgard 184, Dow Corning Corp., Midland, MI, USA) in the 
holder, which was controlled using a 3D positioning stage (EPS 300, Newport 
Corp., Irvine, CA, USA) for precise spatial alignment. 
 
Figure 3.1 Experimental setup of simultaneous optical mapping and infrared imaging. 
Infrared (IR) camera for temperature imaging and high-speed fluorescence CMOS 
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camera for optical mapping for electrophysiology are confocally aligned focusing at the 
upper epicardium of the rabbit heart preparation. The HIFU transducer at the bottom of 
the tissue chamber is facing upwards with its focus at the upper myocardium within the 
field-of-view of the two cameras. The heart is mostly submersed in a Langendorff 
perfusion and superfusion system with only portion of the upper epicardium above the 
solution permitting IR imaging. 
A concave single element HIFU transducer (2.0 MHz, H-148, Sonic 
Concepts, Inc., Bothell, WA, USA) (focal length 63.2 mm and F-number 0.95), 
driven by a signal generator (33250A, Agilent Technologies, Inc., Santa Clara, 
CA, USA) and a 75 W power amplifier (75A250, Amplifier Research, Souderton, 
PA, USA) was used to generate HIFU exposures with a spatial-peak pulse-
average intensity (Isppa) between 2300 to 2900 W/cm2. The transducer was fixed at 
the bottom of the perfusion tank, facing upward with its focus placed on the 
epicardium of either right or left ventricle of the heart preparation through the 
acoustic window. A power meter (PM-1, JJ&A Instruments, Duvall, WA, USA) 
was used to monitor power output. The transducer has a 6-dB focal zone of 0.9 
mm in lateral and 7.2 mm in axial direction measured using a custom fiber optic 
probe hydrophone (FOPH) system.9 
The isolated heart was perfused and stained with di-4-ANEPPS, and 
mapped using the same optical mapping system demonstrated in CHAPTER 2. 
The upper surface of the heart preparation was elevated slightly above the 
solution to allow IR imaging. The IR camera (Silver SC5600, FLIR Systems, 
Boston, MA, USA) was confocally aligned with the CMOS camera to measure 
temperature in the same epicardial surface region of interest (ROI) at 50 frames/s 
and with a focal resolution of ~85 μm. The emissivity of the preparations was 
calibrated to be 0.86 prior to experiments via a black tape method10 which used a 
vinyl electrical tape (Scotch Super33+, 3M Co., St. Paul, MN, USA) with a known 
emissivity of 0.95. 
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The CMOS and IR cameras were synchronized with HIFU via a custom 
programmed FPGA board (Cyclone® II, Altera, San Jose, CA, USA) to record 
optical action potentials (OAPs) and surface temperature of the isolated heart 
during HIFU application. 
3.2.2 Experimental Procedures and Data Analysis 
During experiment, the Langendorff-perfused rabbit heart was under 
sinus rhythm. Following equilibration for 10 – 15 mins, the excitation light was 
adjusted to maximize the signal-to-noise ratio. Single tone burst HIFU exposure 
(duration 10 s) with intensity varying from 2300 to 2900 W/cm2 was applied to 
the heart preparation. After experiment, the heart was photographed (D5000, 
Nikon Inc., Melville, NY, USA), stained with triphenyltetrazolium (TTC, Sigma 
Aldrich, St. Louis, MO, USA)11, and sectioned from mid-line of the HIFU focus 
for gross tissue examination. Gross tissue were then stored in 10 % formalin 
solution for 48 hours, paraffin embedded, and sectioned with 100 μm step size 
across HIFU applied region. Masson’s trichrome (MT) staining was conducted on 
tissue sections and the stained slides were scanned at high resolution (CanoScan 
8800F, Canon USA, Inc., Melville, NY, USA). HIFU-induced lesions were 
identified from the images. 
Each pair of optical mapping image and IR image were registered with 
each other using a control point registration algorithm (Matlab v. 2011b, 
Mathworks, Natick, MA, USA), and are shown in Figure 3.2. Multiple common 
identifiable feature points (8 to 10) on both images were identified and a 
projective transformation was performed on the IR images to compensate the 
error induced by the angle differences between the two cameras. Optical 
mapping data were then processed following the method described in 
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CHAPTER 2. Maps of APA, APD50, APD80, activation, conduction velocities and 
their changes were generated in a similar fashion. 
 
Figure 3.2 Image registration for optical mapping and infrared imaging data. (A) 
Photograph of a rabbit heart preparation. (B) Corresponding infrared (IR) image during 
HIFU ablation (t = 14 s). (C) Background image of optical mapping. (D) Projective 
transformed IR image from (B). (E) Overlaid image of both (C) and (D) based on 
physical landmarks (e.g. atrial-ventricular groove). RA = Right Atrial; LA = Left Atrial; 
RV = Right Ventricle; LV = Left Ventricle; AIVS = Anterior Inter-Ventricular Sulcus. 
HIFU lesion was identified from TTC images of tissue specimens as 
positive (P) whereas non-lesion region was denoted as negative (N). Receiver-
operating characteristic (ROC) analysis was performed on temperature maps at t 
= 14 s (HIFU was applied from 4 s – 14 s) to detect lesion formation, APA 
changes, and APD50 changes. A ROC curve was formed by comparing true 
positive rate (sensitivity) against false positive rate (1 – specificity) at all running 
thresholds and total area under curve (AUC) was calculated to assess the overall 
prediction performance. Optimal temperature threshold for generating lesion 
(lethal isotherm) was then decided to achieve the best detection accuracy. Leave-
one-out cross-validation (LOOCV) was used to determine the variation of the 
overall ROC AUC and optimal thresholds. 
Results were expressed as mean ± standard error of mean (SEM). One-way 
analysis-of-variance (ANOVA) (Tukey-Kramer test for multiple comparisons) 
and paired Student-t test was used for statistical comparisons between groups. 
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Statistical significance was defined as p < 0.05. Linear regression and F-test were 
used for testing linear correlation between different parameters and goodness-of-
fit was assessed by the adjusted R2 and root mean square error (RMSE) of the 
residuals. 
 
3.3 Electrophysiology and Temperature Correlation 
3.3.1 Effect of HIFU on OAPs Baseline 
During HIFU ablation, IR imaging captured the spatiotemporal evolution 
of tissue temperature changes, and a baseline drift of OAPs (red line) were 
observed which was proportional to the temperature increase (Figure 3.3). 
 
Figure 3.3 Changes of OAP baseline and temperature and their correlation. (A) 
Temperature map from infrared (IR) imaging at t = 14.5 s. (B) A representative 
temperature trace at white asterisk labeled location within HIFU focus in (A). (C) 
Corresponding OAPs trace at the same location in (A) with each “spikes” corresponding 
to single cardiac cycle. Red line highlights the baseline of fractional fluorescence signal 
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(∆F). HIFU was on from 4 s to 14 s (blue shaded area). Inset is the zoom in for two OAPs. 
(D) Maps of temperature changes (∆T) and corresponding OAP baseline changes (∆B) in 
the region-of-interest (ROI) in white dashed box in (A). Ratiometric map of ∆B/∆T at 
corresponding times (bottom). Red time indices represent HIFU in situ time. (E) Linear 
regression slope ( /B T  ) for paired ∆B-∆T frames and adjusted R2 as function of time 
(n = 7). HIFU in situ time is during blue shaded period. 
The 2D maps of ∆F baseline (∆B) in a selected ROI (17 × 17 pixels) 
surrounding the HIFU focus and the corresponding temperature changes (∆T) 
appear to be spatiotemporally correlated, especially during HIFU application (4 s 
− 14 s). The ratiometric maps (∆B/∆T) (bottom row in Figure 3.3) at a given time 
point were fairly uniform within the ROI when ∆T was greater than 5 °C, 
indicating a linear relationship between ∆B and ∆T spatially. The linear 
correlation was confirmed through F-test and the overall linear regression slope 
during HIFU heating was (29.91 ± 0.09) × 10-2 %/°C (adj. R2 = 0.78, 16 frames from 
each of the total 7 heart preparations) with a RMSE of 0.27 %. However, linear 
regressions of ∆B and ∆T at different time points showed that ∆B−∆T correlations 
were not uniform throughout entire recording (Figure 3.2E). In particular, the 
linear regression slop increased during HIFU application, especially initially, 
indicating a nonlinear shift of the baseline ∆B with increasing ∆T. The correlation 
of ∆B and ∆T during HIFU (adj. R2 = 0.75 ± 0.04) was also better than during 
cooling period (adj. R2 < 0.5) with smaller variations during heating (< 0.03 %/°C) 
than during cooling (> 0.05 %/°C). 
3.3.2 Mapping of EP and Temperature during HIFU Ablation 
Two dimensional characteristics of cardiac EP including APA, APD, and 
AP triangulation (APD50/APD80) were demonstrated and correlated 
spatiotemporally with temperature changes during HIFU application, and 
temperature-dependent AP changes were derived in the end. 
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(1) Reversible EP Changes 
At HIFU intensities Isppa = 2300 – 2600 W/cm2 and exposure duration of 10 
s, no tissue necrosis was observed in the heart preparation in our experiments (n 
= 9). In these cases, the peak temperature reached 50.1 ± 0.8 °C (45.0 ~ 56.6 °C). 
During HIFU application, OAPs exhibited morphological changes including 
amplitude reduction and shortening of AP duration (Figure 3.4C). After 
cessation of HIFU, the OAP recovered to more than 95 % of the pre-HIFU level. 
Temperature was the highest at the center with a spatial gradient around the 
HIFU focus (Figure 3.4D). A slight asymmetric temperature distribution around 
the HIFU focus was sometimes observed, likely due to heterogeneous 
myocardial fiber and different orientations of microvasculature. 
 
Figure 3.4 Example of a reversible ablation case. (A) Photograph of a gross heart. (B) 
Background image of optical mapping of the same heart with region-of-interest (ROI) 
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encircled by white dash line. (C) Superimposed normalized single OAPs at HIFU focus 
(red) and control (green) site at the color asterisks labeled location in (B) at t = 2 s, 8 s, 13 
s, and 32 s. (D) Temperature maps in the ROI displayed in (B) at indicated time with red 
indices representing frames acquired during HIFU application. (E) Maps of APA 
changes (∆APA) in the same ROI. (F) Maps of APD50 changes (∆APD50). 
Corresponding with the temperature, spatially graded reductions in APA 
and APD50 were apparent around the HIFU focus (Figure 3.4E − F) with a more 
localized region of APA reduction. Activation isochrones were clustered when 
electrical wavefronts propagated across (blue to red) the HIFU focal region with 
activation time delayed by up to 5 ms at the HIFU focus and CV increased by up 
to 1.3 mm/ms (Figure 3.5). Changes in APA and activation patterns appeared to 
recover faster than APD50 after HIFU application. 
 
Figure 3.5 Example of activation changes for reversible case. (A) Activation map prior 
(1.2 s), during (8.3, 10.1, 13.5 s), and post (31.2 s) HIFU ablation for reversible damage 
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(RD). Isochrones are separated at 1 ms step size and blue representing early activation 
and red representing late activation. (B) Maps of conduction velocity (CV) within the 
black box labeled smaller ROI in (A). Red arrows point the direction of electrical 
conduction and their lengths represent corresponding magnitudes of CV. (C) Maps of 
activation delay derived by subtracting averaged activation maps from their pre-HIFU 
state (1 – 4 s). 
Both APA and APD50 appeared to decrease nonlinearly with increasing 
temperature during HIFU ablation, as shown by the ratiometric maps (Figure 
3.6A − B). At the beginning of HIFU heating, ∆APA was small while ∆T was 
large, leading to smaller ∆APA/∆T values. Near the end of HIFU heating, APA 
decreased significantly while increase of temperature slowed down, resulting in 
larger ∆APA/∆T values. In addition, during HIFU application, APA reduction 
outpaced APD50 reduction, demonstrated by the spatial peak at the HIFU focus at 
t = 13.5 s (Figure 3.6C). No significant disproportional APD changes 
(∆APD50/∆APD80) were observed in Figure 3.6D, suggesting no significant AP 
triangulation in these cases with relatively small temperature increases and 




Figure 3.6 Maps of EP and temperature correlation for reversible ablation case. (A) 
Ratiometric maps of ∆APA/∆T in the smaller ROI of white box in Figure 3.4D. (B) 
Ratiometric maps of ∆APD50/∆T in the same ROI. (C) Maps of ∆APA/∆APD50. (D) Maps 
of ∆APD50/∆APD80. 
(2) Irreversible EP Changes 
At a higher HIFU intensity (e.g. Isppa = 2900 W/cm2), tissue necrosis or 
thermal lesions were generated by HIFU application. Lesions had a cross-section 
area of 5.95 ± 0.99 mm2, with an axial depth of 3.55 ± 0.38 mm and lateral width 
of 2.10 ± 0.14 mm (n = 6). In these case, amplitude of OAPs and APD50 reduced by 
32 % and 52 ms respectively, as shown by the OAPs at the representative 
locations (Figure 3.7C). Significant APD reduction (triangulation) was observed 
compared to the cases with reversible EP changes without tissue necrosis, 
indicating that plateau potentials of OAPs were significantly suppressed by 
HIFU ablation. After HIFU ablation at t = 31 s, OAPs amplitude recovered to only 




Figure 3.7 Example of an irreversible ablation case. (A) Photograph of gross heart with 
region-of-interest (ROI) encircled by black dash line. TTC stained tissue specimen with 
lesion in the middle in the smaller ROI in black box. Tissue cross-section was masson’s 
trichrome stained with lesion highlighted by black dash line (inset). (B) Background 
image of optical mapping of the same heart with the same ROI in (A) encircled by black 
dash line. (C) Superimposed normalized single OAPs in the lesion (red) and outside 
(green) HIFU focus at the color asterisks labeled location in (B) at t = 2 s, 9 s, 13s , and 31 
s. (D) Temperature maps in the smaller ROI in (A, black box) at indicated time with red 
indices representing frames acquired during HIFU application. (E) Maps of APA 
changes (∆APA) in the big ROI displayed in (A). (F) Maps of APD50 changes (∆APD50) in 
the same ROI. 
Compared to the cases with reversible EP changes, the spatiotemporal 
evolution of HIFU induced temperature changes showed higher temperature 
increase with the peak temperature reaching 66.4 ± 8.5 °C (52.1 ~ 84.9 °C). Steep 
spatial gradients of temperature and higher peak temperature were seen around 




Figure 3.8 Example of activation changes for irreversible case. (A) Activation map prior 
(1.7 s), during (8.2, 12.3, 13.7 s), and post (31.6 s) HIFU ablation for irreversible damage 
(ID). Isochrones are separated at 1 ms step size and blue representing early activation 
and red representing late activation. (B) Maps of conduction velocity (CV) within the 
black box labeled smaller ROI in (A). Red arrows point the direction of electrical 
impulses conduction and their lengths represent corresponding magnitudes of CV. (C) 
Maps of activation delay derived by subtracting averaged activation maps from their 
pre-HIFU state (1 – 4 s). 
The corresponding spatiotemporal OAPs showed sustained changes of 
APA and APD50 induced by HIFU exposures after cessation of HIFU (Figure 3.7E 
− F). A more significant activation isochronal clustering and changes of CVs were 
seen as electrical wave propagated through lesion area along with a typical 
activation delay “tail” (Figure 3.8). Local activation delay was not sustained as 
HIFU generated lesion was isolated. Similar to the cases with reversible EP 
changes presented earlier, regions with APA changes were smaller than areas 
with APD50 changes, indicating higher thermal sensitivity for cell-cell coupling 
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(related to APD). This is consistent with a lower thermal threshold for APD50 
damage.5 
 
Figure 3.9 Maps of EP and temperature correlation for irreversible ablation case. (A) 
Ratiometric maps of ∆APA/∆T in the smaller ROI of white box in Figure 3.7. (B) 
Ratiometric maps of ∆APD50/∆T in the same ROI. (C) Maps of ∆APA/∆APD50. (D) Maps 
of ∆APD50/∆APD80. 
Again, the reduction of APA and APD50 increased nonlinearly with 
increasing temperature (Figure 3.9A − B). Since these changes of APA and APD50 
were irreversible in these cases with tissue necrosis, ∆APA/∆T and ∆APD50/∆T 
continue to increase after HIFU application as measured at t = 31.6 s when 
temperature was decreasing. Changes of APA outpaced ∆APD50 changes from 
the beginning of HIFU application while significant AP triangulation 
(∆APD50/∆APD80) was also observed around HIFU focus after lesions were 
formed (Figure 3.9C − D), in contrast to the cases with reversible EP changes. 
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3.3.3 Characteristics of EP Changes Correlated with Temperature 
As shown above, we grouped our experimental data into two groups: 
reversible damage (RD) group (n = 9) without lesion generation, and irreversible 
damage (ID) group (n = 6) with lesion formation. As expected, the temperature 
increases in the ID group were significantly higher than those measured in the 
RD group, with a maximum temperature (Tmax) of 50.1 ± 0.8 °C and 66.4 ± 8.5 °C 
for the RD and ID group respectively (Figure 3.10). 
 
Figure 3.10 Temporal traces of temperature and EP parameters. Statistical progression of 
(A) temperature, (B) ∆APA, (C) ∆APD50, and (D) ∆APD80 for reversible damage (RD) and 
irreversible damage (ID) within HIFU focus, and control (Ctrl) in normal tissue. Plots are 
presented as mean ± SEM. HIFU was on from 4 s to 14 s (blue shaded area). 
Corresponding to the temperature increases, ∆APA, ∆APD50 and ∆APD80 
increased during HIFU heating (Figure 3.10B − D). The APA eventually 
recovered after HIFU application for the RD group (− 0.05 ± 0.01), in contrast to 
the sustained or irreversible change observed for the cases in the ID group (− 0.27 
± 0.04) (p << 0.05). However, ∆APD50 showed no significant difference between 
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both groups during HIFU heating, and the values after HIFU exhibited slight 
difference (− 0.13 ± 0.02 and − 0.18 ± 0.03 for RD and ID respectively, p << 0.05), 
suggesting that the APA changes after HIFU were more affected by tissue 
necrosis than APD. 
To illustrate how the EP changes corresponding to temperature changes, 
the values of ∆APA and ∆APD50 within HIFU focus for RD, ID, and control 
(normal tissue outside HIFU focus) were plotted against their corresponding 
temperatures (Figure 3.11). During HIFU heating, the absolute values of ∆APA 
increased with increasing temperature. The increase was slow at lower 
temperatures, but as temperatures reached above 51 °C, larger values of ∆APA 
were detected that were not reversible (ID group). During post HIFU cooling 
(upward arrows in Figure 3.11A), ∆APA recovered for the RD group, with a fast 
recovery initially, in contrast to the irreversible changes for the ID group.  Unlike 
APA, the values of APD50 seemed to increase relative linearly with increasing 
temperature from the beginning of HIFU application (Figure 3.11B). These 
results suggest a lower thermal threshold for generating APD50 changes and a 
dominant thermal effect for HIFU ablation.7 Recovery of APD50 followed similar 
trend (downward arrows in Figure 3.11) for both groups, but the separation 
between the damaging and recovering phases was more significant for ID group, 





Figure 3.11 Correlation between EP parameters and temperature. (A) ∆APA vs. 
temperature, and (B) ∆APD50 vs. temperature for RD, ID, and Ctrl (control) during and 
after HIFU application. Blue and red arrows indicate the direction of the temporal trends 
(damaging and recovery) for each parameter. Data are presented as mean ± SEM. 
3.3.4 Spatial Characteristics of EP Changes associated with Lesions 
For both reversible and irreversible (lesion) cases in this study, we 
observed that the region with APA changes were smaller than the region with 
APD50 changes (Figure 3.12A − B). Midline profiles of temperature and AP 
parameters clearly demonstrated that the temperature decreased with increasing 
distance from the HIFU focus where ∆APA and ∆APD50 were the largest (Figure 
3.12D). Steeper spatial gradient of ∆APA than that for the ∆APD50 was seen. 
Considering the tissue and EP changes, the HIFU ablated area was divided into 
three zones: a lesion zone (e.g. r < 1.05 ± 0.07 mm) where tissue necrosis was 
present with significant reduction of APA and APD50; a transition zone (e.g. r < 
2.00 ± 0.22 mm) with no lesion but with detectable reductions of APA and APD50; 
and a remote zone (e.g. r < 3.79 ± 0.35 mm) where no tissue changes was seen but 
APD50 reduction was evident. Different pathological changes were observed in 
different zones: in the lesion zone (Figure 3.12E), hypereosinophilic stained cells 
were observed, indicating thermal induced protein denaturation, and cellular 
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structures were incomplete with deranged myofibrils and enlarged interstitial 
space; in the transition zone or lesion border zone, an inflammatory rim with 
condensed necrotic band were observed; in the remote zone, cellular structure of 
myocytes were intact with minimum interstitial space. 
 
Figure 3.12 Spatial characteristics of lesion and EP changes. (A) An example of ∆APA 
map at t = 14 s with dash line representing midline. (B) ∆APD50 map at t = 14 s. (C) 
Temperature map at t = 14 s. (D) Midline cross-sectional profiles of ∆APA, ∆APD50, and 
temperature for reversible (D1, n = 9) and irreversible (D2, n = 5) cases. Lesion region is 
indicated by red shaded area. Reversible cases are on the left column and irreversible 
cases are on the right column. (E1) An example of TTC stained lesion with lesion edge 
encircled by white dash line. (E2) Masson’s trichrome (MT) stained slide (20 X) within 
lesion. (E3) MT slide of lesion border. (E4) MT slide of normal tissue outside lesion. (E2 – 
E4) are MT slides for the lesion in (E1). 
By overlaying temperature maps on lesion and binary masks of EP 
determined by a given threshold, we determined the temperature isotherms for 
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generating tissue necrosis, APA, and APD50 changes via ROC analysis (Table 3.1). 
The APA and APD50 masks were generated using threshold values − 0.08 and − 
0.10 which were significantly above the noise level (− 0.05 ± 0.03 and − 0.06 ± 0.04 
respectively). The temperature isotherms were 52.3 ± 1.4 °C, 42.7 ± 0.1 °C, and 
39.6 ± 0.1 °C for lesions, ∆APA, and ∆APD50 respectively. The lower temperature 
isotherms for ∆APD50 than ∆APA again confirmed that APD50 was more 
thermally sensitive than APA, suggesting that cellular plateau potentials were 
more thermally vulnerable than excitabilities. 
Table 3.1 Temperature thresholds for generating lesion, APA loss, and APD50 loss in 
HIFU ablation. Results were derived using receiver-operating characteristic (ROC) 
analysis on pixel-by-pixel basis. 
 Temperature 
 AUC Threshold (°C) 
Lesion (n = 5) 0.84 ± 0.11 52.3 ± 1.4 
∆APA (n = 7) 0.72 ± 0.06 42.7 ± 0.1 
∆APD50 (n = 7) 0.67 ± 0.06 39.6 ± 0.1 
 
3.3.5 Heat Conduction by Vessel in HIFU Ablation 
Blood flow has been known to affect thermal ablation by acting as a “heat 
sink” due to heat conduction.6,12 Here we investigated the effect of perfusion 
cooling on HIFU ablation when the HIFU focus was near a lateral anterior 
descending (LAD) coronary artery (Figure 3.13A, diagonal branch) with an 
intensity of 2900 W/cm2, same as that used in the group with lesion formation. 
However, no lesion was generated in these experiments and reversible EP 




Figure 3.13 Convective heat loss due to perfusion. (A) Photograph of a gross heart with 
region-of-interest (ROI) encircled by white dash line. Diagonal branch of a lateral 
anterior descending (LAD) coronary artery is highlighted by a white arrow. (B) IR 
images during (6.6, 8.7, 10.8, and 13.8 s) and after (16.3, 18.8, and 20.6 s) HIFU ablation 
with convective heat loss indicated by white arrows within the ROI in (A). (C) 
Corresponding APA changes. (D) Changes of APD50. (E) Masson’s trichrome (MT) 
stained lesion with LAD coronary artery aside from the HIFU axial beam. (F) MT slide of 
a HIFU lesion with LAD coronary artery within the field of HIFU beam. HIFU ablation 
was applied along the black arrow pointed direction for both (E) and (F). (G) Zoomed in 
(5 X) of ROI of the white box in (F). Lesion was stained as purple while viable tissue was 
pinkish. 
As illustrated in Figure 3.13B, IR imaging clearly showed the heat 
conduction away from the targeting zone by perfusion in the LAD coronary 
artery (the “tail” near the upper left of ablation zone [white arrow] in Figure 
3.13B). The maximum temperature increase (Tmax) was 51.1 ± 1.4 °C (n = 7), lower 
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than the temperature achieved for the ID group (66.4 ± 8.5 °C). No tissue necrosis 
was detected, and changes of APA and APD50 were transient (Figure 3.13C − D). 
Histological examination further illustrated the cooling effect on ablation. 
Figure 3.13F and G show an example with a LAD coronary artery in the center of 
the HIFU axial beam on a lesion specimen different from Figure 3.13A − D. After 
MT staining, viable myocytes were observed surrounding the LAD coronary 
artery as an evidence of significant heat conduction by the artery during HIFU 
ablation. Compared with the case when LAD coronary artery was outside the 
HIFU beam (Figure 3.13E), an asymmetric lesion along the HIFU beam was 
formed (Figure 3.13F − G). 
 
3.4 Discussion 
In this study, we conducted spatiotemporally correlated optical mapping 
of EP and IR imaging of temperature during HIFU ablation to investigate how 
EP changes were affected by temperature changes. The major findings of this 
study are (1) HIFU induced EP changes included temperature-dependent 
reduction of APA, shortening of APD, activation clustering, and increases of 
conduction velocities around the HIFU focus; (2) tissue EP changes can be 
reversible with temperature increases below 50.1 ± 0.8 °C; (3) irreversible EP 
changes along with tissue necrosis occurred as HIFU-induced temperature was 
above 52.3 ± 1.4 °C; (4) APD50 is more thermally sensitive than APA, and APA 
decreased nonlinearly while APD50 decreased relative linearly with temperature 
increases during HIFU application; (5) HIFU generated irreversible region can be 
divided into three zones with different tissue physical and EP properties; and (6) 
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OAP baseline drifts were linearly correlated with HIFU induced temperature 
rises. We also show the effect of perfusion cooling on EP and temperature during 
HIFU ablation. 
3.4.1 Spatiotemporal Temperature Measurement using IR Imaging 
Direct temperature measurement conventionally relies on the use of 
thermocouples. However, insertion of thermocouples into tissue at discrete 
locations was not always convenient and feasible, and the thermocouples 
themselves also introduced error in temperature measurements by a “heat sink” 
effect via thermal conduction.4 In this mechanistic study, we employed IR 
imaging for temperature measurements at high spatial-temporal resolution (< 
100 µm, up to 50 Hz) in a noncontact fashion. Although limited to surface 
measurements, IR imaging and optical mapping basically acquire signals from 
the same tissue layers (e.g. sub-epicardium) due to spectrum similarity (infrared 
vs. near-infrared VSD emission), therefore providing a well-suited technique to 
obtain temperature maps that can be spatiotemporally correlated with OAP 
signals. 
3.4.2 EP Characteristic Correlated with Temperature 
Significant EP changes including APA reduction, APD shortening, and 
conduction time increases have been observed in hyperthermia, RF, and 
microwave ablation.5,8,13 In this study, we observed similar EP changes for HIFU 
ablation for the first time with finer spatiotemporal resolutions, and the detailed 
dynamics of EP changes were quantitatively investigated. While our results are 
generally consistent with previously reported results, several discrepancies are 
noted due to the advancements of the IR and optical mapping technologies. 
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Reduction of APA was previously reported to linearly depend on 
temperature between 37.0 °C to 49.9 °C with a relatively smaller Pearson’s r 
value (0.54).5 Our results showed that the reduction of APA changed nonlinearly 
following HIFU induced temperature rises, with increasing ∆APA/∆T during 
HIFU application. A turning point in the temporal ∆APA curve (Figure 3.11A) 
suggested a temperature threshold around 42 °C for significant APA changes. 
Employing ROC analysis, we calculated the threshold for generating APA 
changes to be ≥ 42.7 ± 0.1 °C, consistent with previous results (42.7 °C ~ 51.8 °C).5 
Shortening of APD was also observed to be linearly related to temperature 
for hyperthermia (Pearson’s r < 0.5).5 For RF ablation, Wu et al. reported a 
hysteretic behavior of APD80 with ∆APD80/T being large at the beginning of RF 
ablation and being small at the end. A counterclockwise damaging and 
recovering sequence of ∆APD80-T curve was seen, suggesting a combination of 
thermal and electrotonic effects for RF ablation.7 Since HIFU ablation is 
predominantly thermal in our study, ∆APD50-T curve was almost linear during 
HIFU application however with a clockwise damage-recovery hysteresis loop 
during and after HIFU application. Ideally, ∆APD50-T curve during cooling phase 
should follow the same trajectory as heating phase. However, as the peak 
temperature induced by HIFU was around 50 °C, cellular EP property can be 
transiently damaged despite that APD50 recovered completely in the end, leading 
to a slower APD50 recovery and clockwise hysteretic loop. 
The APA and APD50 reduction regions were different with the region of 
∆APD50 being larger than ∆APA, indicating a higher thermal sensitivity for 
APD50. As the APA was the difference between AP peak and the RMP, the 
increases of the RMP caused by temperature increases may result in reduction of 
APA. Earlier work suggested the depolarization of RMP became more prominent 
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when temperature was above 45 °C5, this may potentially explain the threshold 
behavior of the temporal APA changes in our study. Temperature increases from 
25 °C to 35 °C have also been proved to shorten the inactivation period of L-type 
calcium channels and lead to shortened APD, indicating the ionic mechanism for 
a lower temperature threshold for generating APD changes.14 In our study, we 
found the temperature threshold for inducing APD50 change to be ≥ 39.6 ± 0.1°C, 
which was significantly lower than the temperature threshold for causing APA 
changes (42.7 ± 0.1 °C, p < 0.05), although with a relatively low ROC AUC (0.67 ± 
0.06) (Table 3.1). This may be ascribed to the thermal kinetics of different ion 
channels which are beyond the scope of the current study. 
Simultaneous measurements of temperature and EP changes allowed 
categorization of HIFU ablation cases into reversible and irreversible groups 
based on tissue and EP changes including APA and APD. The temperature of 
50.1 ± 0.8 °C corresponding to reversible EP changes may be useful as pre-
ablation test in complex fractionated atrial electrograms (CFAEs) ablations in EP 
research laboratories and clinical settings. Compared with previous research that 
mainly focusing on obtaining HIFU parameters (i.e., acoustic intensity, duty 
cycle, pulse-repetition frequency) based on tissue necrosis alone,1,15-17 
temperature criterions derived from EP characteristics may provide information 
that are more relevant for devising strategies to optimize HIFU ablation to avoid 
recurrence of conduction in atrial fibrillation therapy.18,19 As expected, no 
complete electrical conduction block was observed for irreversible cases because 
of small isolated lesions (Figure 3.8). Three effects including relatively larger 
pixel size (420 – 460 μm) comparing to smaller lesion (~ 2 mm diameter), optical 
scattering and “cross-talking” from adjacent pixels, and AP propagation around 
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and under the non-transmural lesions, combined have caused the conduction 
block being non-sustained. 
With the spatial distributed temperature around HIFU ablation focus, we 
observed similar radial profiles of APA and APD reductions (Figure 3.12) that 
were also observed by other researchers. We further divided the HIFU ablated 
area into three zones: lesion, transition, and remote zones. APA and APD can be 
transiently suppressed or “stunned” within the latter two zones which may help 
to explain some of the late conduction blocks or late recurrence of conduction 
observed clinically.20 
3.4.3 OAP Baseline Changes Measured during HIFU Ablation 
Wu et al. observed the OAP baseline shifts during RF ablation, however 
such baseline change can be prone to artifacts due to tissue-probe contact and 
movement of RF electrode, therefore has not been rigorously quantified.7 In our 
study, as HIFU ablation was performed without direct tissue contact, the OAP 
baseline drift was most likely induced by HIFU generated temperature changes. 
We quantitatively compared the OAP baseline drift with temperature for the first 
time via synchronized measurements of OAP and temperature. Because the 
observed increase in OAP baseline corresponds to a decrease in the total 
fluorescence, we speculate that the reduced fluorescence may result from (1) 
thermal response of the dye21, (2) changes in tissue properties that may affect 
dye-membrane binding, and (3) temperature-induced changes in the resting 
membrane potential (RMP) induced by HIFU exposure. Nath et al. demonstrated 
the RMP followed a sigmoidally-shaped relationship with temperature 
increases.5 In our study, the correlation between OAP baseline and temperature 
increases during HIFU heating appeared to be relatively linear, suggesting the 
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baseline drift was not merely caused by RMP changes. Jin et al. reported a similar 
di-4-ANEP dye with its fluorescence being affected by the membrane status 
which became liquid-disordered above a transition temperature and solid phase 
below the temperature.22 Similarly, in our experiments, the status of the 
myocardial membrane phospholipids could transit into more fluid-like phases as 
HIFU induced temperature crossed certain threshold, making the baseline 
fluorescence drift. Overall, these three mechanisms may all contribute to the drift 
of OAP baseline and each of them cannot be studied in isolation. Determining 
the exact mechanism responsible for this baseline shift may extend beyond the 
scope of this study. 
3.4.4 Perfusion caused Heat Loss during HIFU Ablation 
The “heat sink” effect due to major blood vessel has been documented for 
RF ablation. Especially for ablation at the mitral isthmus (MI), 42 % patients 
showed unsuccessful MI block when ablation was performed close to coronary 
artery.23 HIFU induced heating can be conducted away by blood perfusion in 
treating liver tumors,24 therefore more HIFU energy was needed to achieve 
desired ablation volume. The efficacy of HIFU ablation close to blood vessels 
may depend on the diameter of the vessel and the flow rate of the blood 
perfusion. Using two-dimensional IR imaging, we directly observed heat loss by 
coronary artery flow during HIFU cardiac ablation for the first time. No 
significant EP damage along LAD coronary artery was generated by HIFU. 
Perivascular viable tissue was obtained histopathologically, which can help 
explain the incomplete lesion line in HIFU ablation18 and the late recurrence of 
AF after RF ablation in clinical23. In addition, geometric narrowing of lesion 
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towards the epicardium was observed for most HIFU lesions and this can be 
induced by arterial flow and superfusion. 
3.4.5 Experimental Limitations 
A Langendorff-perfused rabbit heart model was used in this study, thus 
results may vary for other species and differ from in vivo condition. Excitation-
contraction decoupler (BDM) may affect the normal ion channel properties.25 In 
addition, continuous light illumination can weaken BDM and cause photo-
bleaching of the VSD, affecting the accuracy of the OAP measurement. Although 
we corrected photo-bleaching using an exponential model, a dual-wavelength 
ratiometric method may be more appropriate to reduce error.26 Optical mapping 
and IR imaging are technically limited to epicardial measurements due to light 
absorption and scattering across tissue thickness. 
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CHAPTER 4  
Parametric Ultrasound Imaging of 
HIFU Ablation 
Effective intra-procedural imaging techniques are important for guiding 
ablation of AF. However, direct transmural correlation between lesion and 
electrophysiological (EP) changes is difficult. Different from previous chapters of 
using intact heart model, in this chapter, we used a perfused canine ventricular 
wedge preparation to investigate the transmural tissue and EP changes induced 
by HIFU ablation in a spatiotemporally correlated fashion using optical mapping 
described earlier and ultrasound imaging. By correlating with lesion histology 
and EP changes, we demonstrated the feasibility of parametric ultrasound 
imaging for detection lesion and EP changes transmurally during HIFU ablation. 
 
4.1 Overview 
As described in CHAPTER 1, atrial fibrillation (AF) is a common cardiac 
condition occurring in patients with or without overt heart disease.1 Cardiac 
ablation using various energy sources (e.g. radiofrequency, cryo, HIFU) has 
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increasingly become an important treatment option.2,3 However, ablation efficacy 
is often compromised by recurrence of AF episodes after initial procedure. For 
example, 20 % to 40 % patients experience recurrent AF and will need repeated 
ablation procedures.4 This is likely due to incomplete tissue necrosis, ablation 
gaps, and electrical reconnection from tissue healing.5-8 Intra-operative 
electrogram and electroanatomical voltage mapping have been used to confirm 
success of ablation clinically, but it is difficult to precisely relate such surface 
measurements to tissue changes in a transmural plane due to the lack of effective 
imaging technique for detecting lesion and APA changes along the tissue depth 
direction. 
4.1.1 Imaging Technique for Cardiac Ablation 
Various imaging techniques have been developed for assessing thermal 
lesions during ablation. Magnetic resonance imaging (MRI)9, intracardiac 
echocardiography (ICE)10, and fluoroscopy, commonly used to identify anatomic 
structures to guide the placement of ablation catheter, have not provided 
sufficient intra-operative assessment of tissue physical and EP changes. 
Measurements such as tissue electrical impedance11, ablation temperature12, and 
catheter-tissue contact force13 provide useful feedback for energy titration and 
prediction of lesion volume, but accuracies of lesion estimation are suboptimal. 
Direct tissue surface visualization using endoscopy during pulmonary vein 
isolation (PVI)14 cannot provide complete lesion assessment in a transmural 
plane along the tissue depth direction. Optical coherence tomography (OCT), 
with superior imaging resolution, is also limited by imaging tissue depth only up 
to 2 mm.15 
69 
 
Therefore, development of transmural lesion imaging for accurate lesion 
detection and EP assessment can be highly beneficial for ablation guidance. As 
ultrasound imaging has the unique capability to “see” through and into soft 
tissue layers, various advanced ultrasound imaging techniques have been 
exploited to improve its capability for real time monitoring of lesion formation in 
subsurface tissue layers. For examples, Wright et al. showed a novel M-mode 
ultrasound imaging integrated into a radiofrequency ablation (RFA) catheter for 
direct visualization of lesion formation in real time16, demonstrating an 
advantageous approach for image-guided procedures. Kolios et al. demonstrated 
high frequency ultrasound backscatter signals can be used to effectively detect 
apoptotic changes in cell nucleus using spectral analysis method17, indicating 
changes in the nucleus, such as apoptotic, necrosis or other changes, may 
produce detectable signals for high frequency ultrasound imaging for 
monitoring events reflective of cellular level changes. We have previously shown 
that high frequency ultrasound imaging at 55 MHz combined with fast frame 
rate M-mode (1 kHz) and short time B-mode (70 – 130 frames/s) imaging can 
image HIFU lesion and gas body formation18,19 with high accuracy and resolution 
by tracking the temporal history of ultrasound integrated backscatter (IBS) and 
frame-to-frame echo decorrelation. ICE-based acoustic radiation force impulse 
(ARFI) imaging provided improved performance in identifying lesion 
boundaries and dimensions in RFA lesion lines20, although motion artifacts 




4.1.2 Transmural Cellular Electrophysiology 
Electroanatomical mapping combined with pacing technique is used 
clinically for validating ectopic foci isolation after ablation, however, the 
technique is based on surface measurement thus it is difficult to directly relate 
such measurements to transmural tissue status in a three-dimensional (3D) 
space. Given that cellular repolarization varies with the depth of myocardium 
across ventricular wall due to heterogeneous excitation-contraction coupling21,22, 
it is unclear whether cellular EP exhibits different characteristics in different 
transmural tissue layers when lesion is formed in ablation. Using microelectrode 
recording at isolated locations within myocardium, Wood et al. showed similar 
changes of action potential amplitude, duration, and upstroke velocity 
surrounding a RF lesion across epi-, mid-, and endocardium23, however, a 
complete spatiotemporal evaluation of EP changes across the depth of the 
myocardium in a transmural plane during and after lesion formation remains 
unrevealed. 
In this study, in order to investigate the sptatiotemporal changes of tissue 
and correlate them with AP changes in a transmural plane along the tissue depth 
direction during HIFU ablation, we used a perfused canine ventricular wedge 
preparation as a model system which enabled simultaneous ultrasound imaging 
and optical mapping on the same transmural plane during HIFU ablation. 
Although the wedge preparation is not necessarily the best model representing 
an intact heart in vivo, the model system permitted high spatiotemporal 
resolution measurement of EP changes during HIFU ablation using optical 
mapping that can be correlated with ultrasound imaging of the same tissue 
plane, which cannot be achieved with an intact heart either in vitro or in vivo. 
These measurements allowed characterization of the EP changes induced by 
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HIFU ablation, and by correlating with lesion histology, we tested parametric 
ultrasound imaging for detecting lesion and AP changes across the ventricular 
depth direction during HIFU ablation. 
 
4.2 Methods 
4.2.1 Perfused Canine Wedge Preparation 
Animal use was approved by the University Committee on Use and Care 
of Animals (UCUCA) at the University of Michigan. The transmural wedges of 
canine ventricular wall were isolated from mongrel dogs (25 − 40 kg) as 
described before24. Briefly, freshly harvested canine heart was immediately aortic 
rinsed, and arrested with a 4°C cardioplegic solution21. Wedge with a dimension 
of ~ 4 × 1.5 × 1.5 cm with smooth transmural surfaces was dissected using 
microtome blades from the anterolateral or posterior-lateral free wall of either 
left ventricle (LV) or right ventricle (RV) supplied by left anterior descending 
(LAD) coronary arteries or marginal right coronary arteries (RCA) (Figure 4.1). A 
custom flexible plastic cannula was inserted into the section of the artery from 
the base along the wedge length, and major arterial leaks were quickly (< 10 
mins) ligated with suture. Perfusion was validated by injection of Methylene 
Blue dye (Sigma, St. Louis, MO, USA), and poorly perfused wedges were 
discarded. The isolated wedge was then mounted in a tissue holder, placed onto 
a perfusion system, and perfused with oxygenated Tyrode’s solution25 (pH = 7.35 




Figure 4.1 Canine left ventricular wedge preparation. (A) A photograph of a canine heart 
immersed in cardioplegia before wedge preparation. The black box indicates the tissue 
region used on left ventricle (LV). Dash lines highlight marginal coronary arteries. (B) A 
photograph of a coronary perfused left ventricle wedge with epicardium at the left, 
endocardium at the right, apex on top, and base at the bottom of the photograph. HIFU 
energy was delivered from the left. 
The preparation was completely bathed in the same solution and slowly 
warmed up by superfusion. The wedge was then paced from either endocardium 
or epicardium at a cycle length (CL) of 1000 ms until a stable Q-T interval was 
reached on ECG (30 – 40 mins). The ECG and arterial pressure were continuously 
monitored (PowerLab 26T, AD Instruments, Colorado Springs, CO, USA) via 
two floating electrodes to ensure physiological stability of the preparation during 
experiments. After adding excitation-contraction decoupler, 2, 3-butanedione 
monoxime (BDM, 15 mM; Fisher Scientific, Pittsburgh, PA, USA) into the 
perfusate, the wedge was stained with a voltage-sensitive dye (VSD) di-4-
ANEPPS (Invitrogen, Life Technologies, Grand Island, NY, USA) at 15 μM. 
Stabilized for 15 mins, the transmural surface of the wedge was gently pushed 
against a flat acoustically transparent screen (Figure 4.1). 
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4.2.2 Optical Mapping, Ultrasound Imaging, and HIFU Ablation 
Figure 4.2 shows a schematic graph of the experiment setup for 
spatiotemporally correlated optical mapping and ultrasound imaging of HIFU 
ablation. Optical mapping used two green-filtered light emitting diodes (531 ± 45 
nm, 5G Illumination, SciMedia USA Ltd., Costa Mesa, CA, USA) for excitation. A 
100 × 100 pixel CMOS camera system (MiCAM Ultima-L, SciMedia USA Ltd.) 
was used to record the long-pass filtered (> 630 nm) emission fluorescence from 
the transmural surface of the wedge (1000 frames/s and spatial resolution 200 - 
260 μm/pixel). Imaging using M2D-mode (M-mode imaging with a two-
dimensional window size of 17.0 × 5.6 mm) of a Vevo 770 (FUJIFILM 
VisualSonics, Inc., Toronto, Ontario, Canada) was used to acquire the 
backscattered raw radio-frequency (RF) signals (11 frames/s). A RMV 707B probe 
(30 MHz, 12.7 mm focal length, 2.2 mm 6-dB focal depth, and 45 MHz 
bandwidth) was orthogonally and con-focally aligned with the CMOS camera to 
image the same transmural plane (< 0.5 mm variation) of the wedge using a 3D 
measurement procedure. A triangular cut on the edge of the flat polycarbonate 
film (transparent for both HIFU and ultrasound imaging) screen (Figure 4.1) was 





Figure 4.2 Schematic experiment setup of simultaneous optical mapping, ultrasound 
imaging, and HIFU ablation. The HIFU transducer is mounted on a high precision XYZ 
motor stage. Imaging and ablation were synchronized via a custom programmed FPGA 
circuit. 
A concave single element HIFU transducer (3.5 MHz, SU-102, Sonic 
Concepts, WA) driven by a signal generator (33250A, Agilent Technologies, Inc., 
Santa Clara, CA, USA), and a 75W power amplifier (75A250, Amplifier Research, 
Souderton, PA, USA), was used for HIFU application from the epi/endocardial 
surface of the wedge preparation. The HIFU transducer has a focal length of 56.5 
mm and 6-dB focal zone of 0.6 mm (lateral) × 7 mm (axial) measured with a 
custom fiber optic probe hydrophone (FOPH) system.26 The transducer was 
aligned perpendicularly with the ultrasound imaging probe with its focus placed 
slightly (< 0.5 mm) beneath the transmural surface. 
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Optical mapping, ultrasound imaging and HIFU ablation were 
synchronized via a custom-programmed FPGA board (Cyclone® II, Altera, San 
Jose, CA, USA). Synchronized with the continuous 32 s optical mapping, M2D 
ultrasound imaging was from t = 4 s to 8.6 s, and HIFU was applied from t = 4.5 s 
to 8.5 s. M2D backscattered RF signals were digitized using an 8-bit oscilloscope 
(54830B, Agilent Technologies, Inc., Santa Clara, CA, USA) at 100 Mega-sample/s. 
Pulsed HIFU exposure (pulse-repetition-frequency = 11 Hz, duty cycle = 70%, 
duration 4 s, and spatial-peak pulse-average intensity [Isppa] = 3500 ± 300 W/cm2) 
was applied epi/endocardially to generate a single lesion near the wedge 
transmural surface to allow simultaneous optical mapping and ultrasound 
imaging. HIFU pulses were interleaved with M2D ultrasound imaging to avoid 
HIFU interference in ultrasound imaging. Before and after each mapping-
ablation procedure, B-mode ultrasound images with a larger FOV (16.5 × 18.9 
mm), and color photographs of the wedges were obtained. 
4.2.3 Analysis of Optical Mapping Data 
Optical mapping images were analyzed similarly as in CHAPTER 1. 
Briefly, 3 × 3 spatial binning and 1 – 100 Hz FIR band-pass filter were applied for 
spatiotemporal smoothing. The measured optical action potentials (OAPs) were 
normalized to range of between 0 and 1. Activation map was constructed based 
on the time needed for d(ΔF)/dt to reach the maximum value during each cycle, 
where ΔF is the fractional fluorescence change, defined as the change of 
fluorescence signal divided by the background fluorescence. AP duration at 50% 
and 80% repolarization (APD50 and APD80) were calculated as the duration from 
the activation time to 50% or 80% of the peak AP amplitude during 
repolarization. AP upstroke rising rate was defined as (d(ΔF)/dt)max and 
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conduction velocity (CV) was the spatial gradient of the activation time. The 
changes of corresponding AP parameters were calculated by subtraction of the 
average of pre-HIFU frames. A demonstration of optical mapping data 
processing is shown in Figure 4.3. 
 
Figure 4.3 Example of optical mapping data analysis. (A) Sequential images (t1, t2, … , tn) 
were acquired via optical mapping on a canine left ventricular (LV) wedge. Temporal 
recording at each pixel corresponds to optical trans-membrane action potential. Raw 
optical signal is filtered through FIR filter and fractional fluorescence changes (∆F) are 
used to describe optical action potentials (OAPs). (B) Within one cardiac cycle, maps of 
∆F amplitude before high-intensity focused ultrasound (HIFU) ablation are generated. 
Representative OAP traces at color asterisks labeled locations are presented. Since 
perfusion of voltage sensitive dye is not perfectly uniform from endocardium (ENDO) to 
epicardium (EPI), the ∆F amplitude map is non-uniform before HIFU ablation. (C) ∆F 
amplitude map is further normalized to its initial state (temporal average of first 4 ∆F 
amplitude maps). (D) Upon HIFU ablation, normalized ∆F amplitude decreased within 
HIFU focal region and led to OAPs amplitude reduction. The amount of normalized ∆F 
amplitude reduction is defined as ∆APA and the reconstructed ∆APA is illustrated with 
representative OAPs trace. 
4.2.4 Parametric Ultrasound Imaging 
Backscattered RF signals of ultrasound images were collected prior, 
during, and after HIFU application and were processed off-line. The amplitude 
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of Hilbert transformed RF signals, yielded the envelope data A(x, y; t), which 
was used to form various ultrasound parametric images as described in earlier 
works.18,27 Briefly, gray-scale (GS) ultrasound images were computed as the 
logarithmic compression of the envelope data (in decibels)18 
10( , ; ) 10log ( ( , ; ) )GS x y t A x y t    4.1 
Integrated backscatter (IBS), a parameter related to acoustic impedance of 
the tissue, was calculated as the averaged power spectral density over a limited 
bandwidth (in decibels)18 
2
10( , ; ) 10log ( ( , ; ) )IBS x y t A x y t    4.2 
Rayleigh distribution parameter (α, Eq. 4.3) and scale parameter of log-
normal distribution (σ, Eq. 4.4), both reflecting the spatial organization of 
ultrasonic scatters, were calculated based on the spatial intensity distribution of 
the envelope data using a maximum likelihood estimates (MLE) method27 
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Figure 4.4 shows an example of generating Rayleigh and log-normal parametric 




Figure 4.4 Example of generating ultrasound parametric images. (A) An ultrasound 
M2D-mode envelope image is presented with a red rectangular window (100 × 13 
pixels). (B) Histogram of pixel intensity within the red window in (A) is plotted as blue 
bars. Histogram is fitted using probability density functions of Rayleigh (Rayl, green) 
and log-normal (Logn, red) distribution model. Rayleigh and log-normal parameters are 
estimated using MLE method. (C) Rayleigh image with the green asterisk labeled pixel 
indicating α value in the red window. (D) Log-normal image with the red asterisk 
labeled pixel indicating σ value in the red window. 
The temporal evolution for any given ultrasound parameter X(x, y; t) 
defined in Eq. 4.1 – Eq. 4.4 is then calculated as the following 
( , ; ) ( , ; ) ( , ; 1)tX x y t X x y t X x y t      4.5 
( , ; ) ( , ; ) ( , ;0)cX x y t X x y t X x y      4.6 
max
'
( , ; ) max ( , ;0 ' )
t
X x y t X x y t t     4.7 
Transient change of X is defined as the absolute difference between two adjacent 
frames (Ep. 4.5). Cumulative change of X is the absolute difference between the 
current frame at t and the average of pre-HIFU recording. Cumulative extrema is 
the temporal maximum of the transient changes. This function captures the 
entire time history of any parameter changes which occurred during HIFU 
application. Figure 4.5 shows an example of the transient change, cumulative 
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change, and cumulative extrema of grayscale image. The temporal changes for all 
parametric images were normalized in the end for further analysis. 
 
Figure 4.5 Example of temporal changes of gray-scale images. (A) Horizontally stacked 
gray-scale (GS) M2D-mode ultrasound images in decibels [dB] with blue dash lines 
representing the start and cessation of HIFU ablation. (B) Transient changes of GS 
images. (C) Cumulative changes of GS images. (D) Cumulative extrema of GS images 
with normalization. 
4.2.5 Histology, Lesion Assessment, and Image Registration 
Immediate after each ablation trial, wedge preparations were stained with 
triphenyltetrazolium (TTC, Sigma Aldrich, St. Louis, MO, USA) following a 
previously described protocol28 and were photographed again. Finally, all wedge 
tissues were stored in 10 % formalin for > 48 hours. Formalin-fixed tissue blocks 
were paraffin-embedded, sectioned at 5 μm and went through masson’s 
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trichrome (MT) staining. MT stained slides were scanned using a high resolution 
scanner (CanoScan 8800F, Canon USA, Inc., Melville, NY, USA) and the 
boundaries of HIFU induced lesions were identified  using  a custom semi-
automatic Matlab algorithm (v. 2012b, Mathworks, Natick, MA, USA). Briefly, 
color-based segmentation using k-means clustering and simple Markov random 
field (MRF) model were used to differentiate lesion from normal tissue. 
Algorithm detected lesion masks were then combined with hand-picked lesion 
contours to further reduce detection errors. Lesion boundaries detected from 
images of MT slides, TTC stained images, and photographs of gross tissue 
showed high similarity (> 98 %). Due to potential artifacts associated with 
histology preparation (e.g. tissue deformation during embedding and slicing), 
we used gross images taken immediately after experiments to detect lesion 
boundary for ultrasound parametric imaging analysis. 
Ultrasound M2D images, tissue gross photographs, and optical mapping 
images were registered based on the fiducial marker (red asterisk) on the flat 
imaging screen as depicted in Figure 4.6. MT stained slides and tissue gross 
photographs were also registered via lesion geometry (e.g. lesion centroids). A 
representative example of registered images was shown in Figure 4.6. The 
region-of-interest (ROI) in M2D imaging window (green box) was further 
reduced to 6 × 5.6 mm for further analysis. 
Receiver operating characteristic (ROC) analysis was performed to 
determine whether HIFU induced ∆APA corresponds to lesion. ROC analysis 
was also performed to test ultrasound imaging parameters we used for detecting 
lesion and ∆APA. Leave-one-out (LOO) cross-validation was employed to 
determine the variation of ROC analysis. Results are presented as mean ± 
standard deviation unless specified otherwise. Kruskal-Wallis ANOVA were 
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used for statistical comparisons between groups and p < 0.05 was considered 
statistical significant. 
 
Figure 4.6 Ultrasound, gross, optical, and histological images registration. (A) 
Ultrasound B-mode image of a wedge preparation after HIFU ablation. Green box 
indicates the field-of-view (FOV) of M2D imaging and red asterisk at a corner of the 
fiducial marker on the acoustic transparent screen. ENDO = endocardium, EPI = 
epicardium. (B) Photograph of the same wedge with purple asterisk labeling the lesion 
centroid. (C) Background optical mapping image. M2D, gross, and optical images were 
registered based on the FOV and fiducial marker. (D) Masson’s trichrome (stained) 
microscopic slide of the same transmural plane. (E - J) Registered FOV of M2D image, 
gross image, lesion mask from gross image, background optical image, MT slide, and 




4.3 Transmural Lesion and EP Imaging 
4.3.1 Transmural Optical Mapping of Canine Wedge 
The OAPs, activation pattern, and APD measured from the perfused 
wedge preparations in this study, whether pacing either endocardially (n = 7) or 
epicardially (n = 6), are consistent with reported results.24 Figure 4.7 shows an 
example of a canine LV wedge preparation under a pacing rate of 60 bpm (CL = 
1000 ms), showing systematic activation and steep spatial APD80 gradient from 
epicardium to endocardium transmurally with shorter APD80 near the 
epicardium and longer APD80 near the endocardium. The observed AP 
morphology at different layers was consistent with that under normal sinus 
rhythm, indicating sufficient perfusion, cell-cell coupling, and absence of 
ischemic regions in the wedge preparation.21 The perfused preparations were 
viable with normal EP for over 3 hours and all experiments were performed 
within this period. 
 
Figure 4.7 Electrophysiology and OAPs of a canine left ventricular wedge preparation. 
(A) Activation map superimposed on the photograph of the transmural surface of the 
wedge. The large black box is the region of interest for optical mapping. The color 
asterisks indicate locations where OAPs were plotted. Pacing (cycle length = 1000 ms) 
was applied from the epicardium. (B) APD80 map superimposed on the same wedge. (C) 
Representative OAPs at subepicardium (EPI), midmyocardium (MID), and 
subendocardium (ENDO) indicated by the colored asterisks in (A) and (B). 
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4.3.2 Transmural EP Changes and Lesion generated by HIFU 
HIFU generated single lesion, either cigar-shaped (n = 4) or tadpole-
shaped (n = 9), as indicated by the pale or discolored region in gross photograph 
and MT stained slide, were 12.27 ± 2.03 mm × 2.86 ± 0.57 mm (n = 13) along the 
depth of ventricular wedges (Figure 4.8). Lesion regions detected from MT 
images, TTC stained images, and gross photographs showed high similarity (> 
98% pixel-by-pixel match). 
Microscopically, condensed cytoplasmic filament and loss of cellular 
structure were observed near the center necrotic area. A border zone was seen as 
a rim of necrotic contraction band with apparent hemorrhage or inflammation 
but intact cell structures. Outside the border zone, cardiomyocytes were intact 
(Figure 4.8). No microscopic cavity was observed on the lesion MT slides, 
suggesting minimum effects from high temperature related “boiling” or HIFU 
induced cavitation. Correspondingly, different EP characteristics were observed 
within and surrounding HIFU lesions in the ventricular transmural plane. Near 
the lesion center, significant APA reduction (~80 %) was accompanied by 
significantly more APD shortening, AP triangulation, and reduced upstroke 
rising rate (Figure 4.8). Fewer changes were seen in the border zone and no 
changes were observed in tissue regions further away (Figure 4.8). 
Overall higher APA reduction was seen near lesion center than in border 
zone (n = 13). Similarly, APD50 and APD80 shortening (up to 33 % and 21 % 
respectively) were more severe near the center than in border zone. However, 
shortening of APD extended up to 2.8 mm for APD50 and 2.0 mm for APD80 
beyond lesion boundary or region of APA reduction. Transmurally, more APD 
reduction was seen near epicardium than endocardium, implying different 
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thermal resistivity across ventricular wall. Decrease of APD50/APD80 (from 0.8 to 
0.74) suggested influence of HIFU on the plateau potential. 
 
Figure 4.8 Spatiotemporal changes of transmural EP of wedge preparation around HIFU 
lesion. (A) Photograph of a LV wedge with HIFU lesion. (B) Masson’s trichrome (MT) 
stained slide of the same wedge with lesion. Black dash line encircles lesion boundary. 
Black asterisks label representative locations inside lesion, border, and normal tissue. (C) 
Microscopically magnified (40X) MT histology images at asterisks labeled locations in 
(B): lesion (a1), border (b1), and normal tissue (c1). Corresponding normalized OAPs (a2 
– c2) before (blue) and after (pink) HIFU ablation. (D) Amplitude map of ∆F before and 
24 s after HIFU ablation, and the percentage difference (∆APA) with dashed line 
representing the same lesion in (B). (E) Maps of APD50 before and after HIFU ablation 
and their percentage difference (∆APD50). (F) Maps of APD80 before and after HIFU and 
∆APD80. (G) Maps of the ratio between APD50 and APD80 before and after HIFU ablation, 
and ∆APD50/APD80. (H) Maps of upstroke rising rate (d∆F/dt)max before and after HIFU, 
and their difference. (I) Activation maps before and after HIFU, and their difference. (J) 
Conduction velocities (CVs) map before and after HIFU superimposed on the activation 
maps in (I). Directions of electrical wave propagation and magnitude of CVs are 
indicated by the directions of the red arrows and their lengths. Zoomed-in local CVs 
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(right column) around HIFU lesion within the ROI (dashed white boxes) in the global 
CVs maps (left and middle columns in J). 
Suppression of cellular excitability within lesion after HIFU ablation was 
indicated by a reduction of upstroke rising rate from 0.19 %/ms to 0.11 %/ms. 
Although no transmural conduction block for the single lesion was seen on 
activation map, local activation delay up to 5 ms was observed close to the 
epicardial pacing site and minor early activation (2 ms) occurred in the lesion 
center. The propagating wavefront bifurcated in the lesion axial direction and 
increased CVs were seen along the edge of the lesion (Figure 4.8). Bipolar pacing 
confirmed loss of excitability in lesions (Figure 4.9). No propagating APs were 
observed when pacing at lesion center, while pacing provoked AP propagation 
was generated when pacing was near the border of lesion and normal tissue. 
 
Figure 4.9 Activation maps with pacing at various locations relative to a HIFU lesion. 
(A) Photograph of a canine LV wedge preparation after HIFU lesion formation with 
epicardium (Epi) on the right and endocardium (Endo) on the left. Lesion is indicated by 
the arrow. (B) Activation map superimposed on the LV wedge in (A) before HIFU 
ablation with pacing placed close to the base of the wedge. (C) Activation map after 
HIFU ablation with pacing placed below the lesion and close to the base. (D) Activation 
map after HIFU ablation with pacing placed in the center of the lesion. No electrical 
activation was provoked from the pacing site whereas spontaneous activation was 
initiated from earlier pacing site. (E) Activation map after HIFU ablation with pacing at 
the epicardial side of the lesion, resulting in a reformatted activation pattern. (F) 
Activation map after HIFU ablation with pacing above the lesion close to apex. 
Activation was reestablished with origin at the pacing. Pacing threshold was 2X 
threshold voltage (6V) for all experiments. Isochrones of activation map was separated 
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with step size of 1 ms with blue representing early activation and red representing late 
activation. Pacing electrode blocked the view of optical mapping and caused missing 
areas on all activation maps. 
4.3.3 Spatiotemporal Characteristics of AP Changes during HIFU 
Baseline changes of fluorescence signals (∆F) from optical mapping were 
observed during HIFU ablation (Figure 4.10). CHAPTER 3 determined that such 
baseline changes correlated with tissue temperature changes induced by HIFU 
ablation. Analysis of EP changes in this study was performed after baseline drift 
correction. 
In addition to spatial distribution of OAP changes, we observed that OAP 
exhibited little recovery within the lesion but partial recovery in the lesion border 
zone after HIFU application. Compared to HIFU induced APA reduction, APD50 
shortening extended to larger spatial region and occurred faster than ∆APA 
during HIFU application (shaded areas in Figure 4.10). Furthermore, less 
recovery of APA than APD50 occurred after HIFU application when tissue 
gradually cooled down. These observations indicate that plateau potential 
(related to APD) is more thermally sensitive than excitability (associated with 




Figure 4.10 Acute changes of AP prior, during, and after HIFU ablation. (A) Changes of 
OAPs amplitude (∆APA) at t = 32 s superimposed on background optical mapping 
image (gray scale). Black box represents the ROI (6 × 5.6 mm) within the field-of-view of 
M2D ultrasound imaging. Colored asterisks label representative locations inside lesion, 
border, and normal tissue. (B) Normalized OAPs at the labeled locations in (A). Cyan 
shaded area indicates HIFU duration. Single cycle OAPs at t = 1.8, 8.8, 17.8, and 31.8 s 
indicated by a, b, c, and d. (C) Normalized OAPs at the labeled locations in (A) 
superimposed at corresponding times (arrows a – d in B). (D) Spatiotemporal changes of 
∆APA. Blue labeled frames were during HIFU ablation. (E) Spatiotemporal changes of 
∆APD50. (F) Normalized ∆APA and (G) ∆APD50 at representative locations (asterisks in 
D and E). 
88 
 
4.3.4 HIFU Lesion vs. OAP Changes 
We determined the threshold of ∆APA corresponding to HIFU lesion 
(Figure 4.11). Based on a lesion mask obtained from gross photograph and MT 
slide with corresponding ∆APA map at t = 32 s, histograms of the ∆APA values 
at pixel locations inside (n = 2058) or outside lesion mask (m = 4117) (from 13 
preparations) show that APA reductions inside lesion (− 0.57 ± 0.16) was 
significantly higher than outside (− 0.16 ± 0.15) (p << 0.05). The ROC curves of 
∆APA using all preparations yielded an averaged ROC area-under-curve (AUC) 
of 0.96 ± 0.01. The optimal threshold of ∆APA for detecting lesion was − 0.43 ± 
0.01 and the corresponding predicted lesion (Figure 4.11, inset) matched 
precisely with lesion histology. LOO test yielded an ROC AUC of 0.88 ± 0.07, 
confirming the stability of the detection method. 
 
Figure 4.11 OAPs changes within and outside a HIFU lesion. (A) Photograph and 
masson’s trichrome stained slide of a wedge preparation after HIFU ablation (top panel) 
along with the binary lesion mask (lesion as white) (bottom penal), ∆APA at t = 32 s. 
Black dash lines indicate lesion region. (B) ∆APA (n = 13) within lesion and outside 
lesion (non-lesion) determined by lesion mask. A black dash line indicates a ∆APA 
threshold (- 0.43 ± 0.01) for predicting HIFU lesions determined from receiver-operating 
characteristic (ROC) analysis. (C) ROC curves for ∆APA detection of lesion for all cases 
(individual and overall curves are marked pale and red respectively) with an area under 
ROC curve (AUC) of 0.961. Inset: ∆APA predicted lesion (red) for the example in (A) is 
overlaid on the real binary lesion mask. 
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4.3.5 Lesion Detection using Optical and Ultrasound Imaging 
A clear region of APA reduction was readily identified from optical 
mapping, but lesion identification was difficult from regular B-mode gray-scale 
ultrasound images (Figure 4.12). 
 
Figure 4.12 Example of optical mapping and ultrasound imaging of lesion growth. (A) 
Selected ∆APA maps prior, during, and after HIFU ablation. HIFU ablation was applied 
from t = 4.55 to 8.55 s. (B) Selected grayscale ultrasound images (from t = 4 to 8.64 s) 
corresponding to the ∆APA maps in (A). Frames during HIFU ablation are labeled with 
blue time indices. 
Assuming lesion corresponding to ∆APA threshold of − 0.43 ± 0.01, 
parametric images using |∆GS|max, |∆α|max, and |∆σ|max yielded the best AUCs, 
0.82 ± 0.03, 0.89 ± 0.02, and 0.89 ± 0.01 respectively (Table 4.1), much better than 
conventional B-mode (0.53 ± 0.01). The ROC AUCs increased significantly until 
the end of HIFU application (t = 8 s, n = 4) (Figure 4.13), as detection sensitivity 
increased correspondingly. Stability of the prediction was confirmed by LOO 
cross-validation. Since |∆σ|max generated the highest ROC AUCs (optimal 




Table 4.1 The area under the receiver-operating characteristic curve (ROC AUC) for 









Gray-scale change (tran.) [dB] |∆GS|t 0.53 ± 0.01 5.09 ± 1.84 
Gray-scale change (cumu.) [dB] 
Gray-scale change (cumu. extrm.) 
IBS change (cumu.) [dB] 
IBS change (cumu. extrm.) 






0.64 ± 0.03 
0.82 ± 0.03 
0.65 ± 0.03 
0.71 ± 0.06 
0.69 ± 0.04 
5.43 ± 1.28 
0.44 ± 0.16 
10.50 ± 2.10 
0.46 ± 0.22 
0.11 ± 0.14 
Rayleigh α change (cumu.) 
Rayleigh α change (cumu. extrm.) 




0.77 ± 0.03 
0.89 ± 0.02 
0.64 ± 0.05 
0.16 ± 0.03 
0.11 ± 0.02 
0.12 ± 0.11 
Log-normal σ change (cumu.) |∆σ|c 0.75 ± 0.01 0.18 ± 0.01 
Log-normal σ change (cumu. extrm.) |∆σ|max 0.89 ± 0.01 0.28 ± 0.01 
 
Based on the ∆APA threshold (− 0.43 ± 0.01) and |∆σ|max threshold for 
lesion identification (0.28 ± 0.01), we constructed color coded parametric images 
of ∆APA and |∆σ|max showing temporal evolution of lesion formation, where 
lesion region identified from optical mapping (blue) and parametric ultrasound 
images (red) were superimposed on gray-scale B-mode ultrasound images 
(Figure 4.13). Compare to ∆APA, |∆σ|max imaging overestimated lesion area 
during the first 2 s of HIFU ablation, but its performance improved significantly 




Figure 4.13 Lesion detection using optical mapping and ultrasound imaging. (A) 
Temporal changes of the ROC area-under-curves (AUCs) for |∆GS|max (black), |∆α|max 
(blue), and |∆σ|max (red), with maximum at t = 8.03 ± 0.19 s (black dash box). (B) 
Temporal changes of lesion detection accuracy, sensitivity (true positive rate), and 
specificity (true negative rate) using |∆σ|max. (C) M2D-mode image color-coded by lesion 
map determined by ∆APA threshold (cyan). (D) M2D images color-coded by lesion 
region determined by cumulative extrema of log-normal parameter |∆σ|max (red). (E) 




4.3.6 Parametric Ultrasound Imaging vs. ∆APA 
In addition to detecting ∆APA associated with lesion (< − 0.43), ultrasound 
distribution parameters α and σ outperformed other parameters in detecting 
smaller ∆APA (between − 0.19 and − 0.43) that were not correlated with lesion 
during HIFU ablation. An arbitrary value − 0.19, significantly above the noise 
level (− 0.07 ± 0.12), was chosen. Again, the cumulative extrema of the ultrasound 
parameters yielded higher AUC than transient and cumulative changes. Figure 
4.14 shows the ROC AUCs of |∆σ|max for detecting ∆APA associated with lesion 
and non-lesion at different times. Compared with ROC AUC of |∆σ|max for 
detecting lesion-related ∆APA (0.89 ± 0.01), detection of non-lesion ∆APA 
achieved an AUC of 0.79 ± 0.03. Similarly, ROC AUCs improved with time, with 
increasing detection sensitivity correspondingly.  
 
Figure 4.14 Temporal ROC analysis of APA detection using parametric ultrasound 
imaging. (A) Temporal changes of the ROC area-under-curves (AUCs) using |∆σ|max for 
detecting lesion and ∆APA below lesion threshold (non-lesion). (B) Temporal changes of 
detection accuracy, sensitivity (true positive rate), and specificity (true negative rate) 
using cumulative extrema of log-normal parameter (|∆σ|max) for detection of lesion and 
peripheral ∆APA regions. 
Figure 4.15A shows an example of color coded ∆APA images for lesion 
(∆APA < – 0.43) in blue and non-lesion regions (– 0.19 < ∆APA < – 0.43) in green. 
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Figure 4.15B − C is the color coded |∆σ|max images for detecting ∆APA within 
lesion (red) and non-lesion (yellow), with overestimation of areas associated with 
non-lesional ∆APA. 
 
Figure 4.15 Example of APA detection using ultrasound parametric imaging. (A) M2D 
image color coded by true lesion region (∆APA < - 0.43, blue) and non-lesional ∆APA (- 
0.43 < ∆APA < - 0.19, green) determined from ∆APA maps. (B) Gray-scale M2D images 
color coded with lesion (red) and non-lesional ∆APA (yellow) regions determined from 
|∆σ|max images. Blue time indices indicate frames during HIFU application. (C) Stacked 




Using optical mapping and ultrasound imaging, we investigated HIFU 
induced tissue and EP changes transmurally in a spatiotemporally correlated 
fashion in perfused canine wedge preparations. We demonstrated that 
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parametric ultrasound imaging using cumulative extrema of the log-normal scale 
parameter σ (|∆σ|max) can differentiate HIFU generated lesion and small ∆APA 
around the thermal lesions. To note, the proposed imaging technique, which is 
potentially useful for intra-operative identification of lesion transmurality, can be 
applied in other ablation modalities such as RF and laser ablation as well, and 
can help improve the efficacy of current ablation procedure in clinical practice. 
4.4.1 Spatiotemporal Changes of APA and APD around Lesions 
Our results of the spatiotemporal changes of EP induced by HIFU 
ablation, such as reduction of APA and shortening of APD, in the transmural 
surface of the wedge preparations are in general agreement with the reported EP 
data recorded epicardially and intracardially.23,29,30 Although HIFU generated 
lesion and EP changes in our study showed similar properties to RF lesions, 
several findings are worth noting. 
Significant reduction in electrogram amplitude (e.g. 80 %) has been used 
clinically31 to confirm ablation. However, no universal endpoint for single 
ablation has been well defined. In this study, we determined a threshold of 
∆APA (43 ± 1 %, n = 13) that best demarked single lesion region validated by 
histology. The more conservative reduction may be necessary clinically to reduce 
the risk of electrical reconnection. 
Shortening of APD50 and APD80 extended beyond the lesion boundary 
(Figure 4.8 and Figure 4.10), as well as triangulation, consistent with the reported 
results using RF ablation.23 APD50 and APD80 occurred faster than and prior to 
APA reduction (Figure 4.8 and Figure 4.10), and there was also larger recovery of 
APD than APA after HIFU application during tissue cooling, suggesting a more 
thermally sensitive characteristics of the ion channels (thus plateau potentials) 
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than cell excitability and a more stable measurement of EP changes using APA 
instead of APD. In addition, less reduction in APD80 compared to APD50, firstly 
reported by Wood et al. in RF ablation23, was also observed in HIFU lesion. 
Triangulation was < 20 % within lesion and on lesion border zone (Figure 4.8). 
Possible mechanisms include suppression of L-type Ca2+ current, delayed 
outward K+ current, and inward rectifier K+ current when temperature across 
certain threshold. 
Optical mapping in a transmural surface revealed early activation within 
the HIFU lesion and local activation delay at locations proximal to pacing site, 
suggesting the effect of the intricate alignment of myocardial fibers across the 
transmural ventricular wall. Conduction velocities increased along the edges of 
HIFU lesions, similar to the observations in RF lesions.23,32 
4.4.2 Lesion Assessment using Ultrasound Imaging 
Superior tissue penetration of ultrasound imaging compared to other 
imaging methods such as endoscopy or optical coherent tomography makes it a 
suitable tool for real time transmural monitoring of lesion formation, as observed 
in ablation in an in vivo sheep model.16 However, conventional ultrasound 
imaging has not provided sufficient contrast to detect lesions accurately. 
Eyerly et al. demonstrated an novel ICE base ARFI imaging technique 
using a 6.15 MHz imaging probe for identifying RF generated lesions and 
discontinuous lesion set.20 But the imaging rate of ARFI was less than 4 
frames/min and the imaging quality was affected by the probe placement and 
cardiac motions. Wright et al. introduced a novel system that combined 
ultrasound imaging with ring or polymethylpentene (TPX) covered RF catheters 
to directly visualize lesion formation in real time.16 We have previously shown 
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that high frequency ultrasound imaging at 55 MHz combined with fast frame 
rate M-mode (1 kHz)19 and short time B-mode (STBM) (frame rate 70 – 130 Hz)18 
imaging can detect HIFU lesion and gas body formation by tracking the temporal 
history of changes in ultrasound integrated backscatter (IBS) and frame-to-frame 
echo decorrelation. In the current study, we employed lower ultrasound imaging 
frequency at 30 MHz with a deeper imaging depth (~12.7 mm) which is more 
suitable for imaging across the depth of human atrial tissue (5 – 7 mm). Using the 
∆APA threshold corresponding to the histological lesion, we showed that 
statistical parameters such as Rayleigh and log-normal parameters performed 
better than the parameters employed previously in predicting lesion formation 
and sizes. 
Both Rayleigh and Non-Rayleigh (e.g. K-distribution and Nakagami 
parameters) distribution methods have been employed to differentiate infarcted 
myocardium from normal heart in studies using imaging frequency below 15 
MHz.27,33 In this study, we showed that statistical parameters such as Rayleigh 
and log-normal parameters performed better than other parameters, suggesting 
the ultrasound scatters (e.g. cell nucleus) within HIFU lesions were most likely 
poly-dispersed and non-periodic.34 However, the detection accuracies between 
Rayleigh and Nakagami method were marginal. The cumulative extrema of the 
parameters, which captured the temporal evolution of the backscatter changes 
during HIFU ablation, performed better than transient and cumulative changes. 
For example, ROC AUC increased by 20 % using cumulative extrema of |∆σ|. In 
addition, the spatial resolution with Rayleigh and log-normal imaging was fine 
enough to image small size lesions (98 μm in axial and 115 μm in lateral), 




4.4.3 Ultrasound Imaging of APA Changes 
Our results show that histological lesion regions matched well with 
spatial map of APA reduction above a threshold (Figure 4.8), suggesting a link of 
cell morphological damage (e.g. loss of cellular nuclei, myocardial fiber 
dissolution, damaged plasma membrane and gap junctions) (Figure 4.8C) with 
cellular EP changes including the loss of AP and inter-cellular electrical 
conductivity.35 
Although it is the significant irreversible ∆APA combined with lesion that 
is relevant for intra-operative ablation guidance, it is also important to gauge 
smaller changes of APA because Wood et al. observed that cellular EP within 
lesion border zone completely recovered 22 ± 13 days after RF ablation,23 which 
may be responsible for arrhythmia recurrence. We demonstrated that parametric 
ultrasound imaging can accurately detect lesion thus irreversible changes of APA 
during HIFU ablation and also smaller APA changes although with less 
accuracy. 
4.4.4 Experimental Limitations 
In vitro preparations of canine ventricular wedges that are mechanically 
stabilized using BDM have inherent physiological differences from in vivo 
beating hearts. A more appropriate decoupler, blebistatin which has less side-
effect on cellular EP than BDM36, should be used. In this study, ultrasound 
imaging and optical mapping were performed on the same transmural tissue 
surface of a wedge preparation, which may be different from a transmural plane 
within a 3D tissue. Optical mapping provides relative AP values and can only be 
used for in vitro study. Since we used a 30 MHz imaging system for high spatial 
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imaging resolution, to extrapolate this to in vivo implementation for ablation 
monitoring, further studies will be required to examine the effects of imaging 
frequency, imaging beam characteristics, as well as ECG-gating for motion 
tracking to suit for beating heart conditions. As a preclinical proof-of-principle 
study, we were able to image the lesion and AP changes on the ablation plane 
parallel to the ablation axis along tissue depth direction. Ideally, ultrasound 
imaging transducer shall be co-axially aligned with ablation probe as Wright et 
al. presented earlier16, therefore, further efforts are needed to fabricate dual-
element transducers for co-axial ablation and imaging. Furthermore, the 
temperature during ablation was not monitored directly, thereby whether 
ablation induced “boiling” occurred and the effects of gas body activities and 
cavitation on the performance of the parametric imaging techniques for lesion 
and EP detection were not fully investigated. 
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CHAPTER 5  
Conclusions and Future Works 
This dissertation has demonstrated the feasibility of using optical 
mapping technique to investigate HIFU thermal effects on cardiac cellular 
electrophysiology (EP). EP changes during HIFU are characterized and 
correlated with temperature measurements. Detailed spatiotemporal EP-
temperature correlation enhances our understanding about HIFU cardiac 
ablation. The demonstrated HIFU-temperature dosage information will 
hopefully provide valuable information for planning HIFU cardiac ablation and 
designing temperature feedback schemes. Ultrasound parametric imaging 
techniques developed in this work provide a new prospect of imaging lesion and 
action potential changes simultaneously during HIFU ablation. Combined, this 
work may help increase the safety and efficacy of HIFU ablation and advance the 
application of the HIFU technology in cardiac ablation. Future work in HIFU 
technique will focus on developing safe HIFU ablation technique to reduce HIFU 
related complications and to explore other potential effects of therapeutic 
ultrasound on cardiac EP. This chapter aims to summarize and combine the 




In this dissertation, three specific aims are achieved. First, we successfully 
demonstrated using optical mapping to continuously monitor HIFU induced 
cardiac EP changes in Langendorff-perfused rabbit whole heart model in real 
time. The details described in CHAPTER 2 build the methodological foundation 
to carry out experiments in the rest studies.  
By combining infrared imaging, we then systematically explored the 
spatiotemporal correlation between HIFU induced EP changes and 
corresponding temperature increases during and following HIFU ablation in 
CHAPTER 3. We find cardiac EP changes during HIFU application are 
predominantly thermal mediated. HIFU-generated APA reduction, APD 
shortening, activation distortion, and local conduction velocities increases are 
temperature dependent: temperature below 50.1 ± 0.8 °C only lead to reversible 
EP changes while temperature above 52.3 ± 1.4 °C can induce irreversible tissue 
physical and EP changes. Temperature thresholds for generating APA reductions 
are > 42.7 ± 0.1 °C and > 39.6 ± 0.1 °C for causing APD shortening, confirming the 
hypothesis that APD is more thermal sensitive than APA. Compounding both 
tissue histopathology and EP, we find an ablation transition zone which can help 
explain electrical reconnection in clinical ablation. Major vessels related to the 
“heat sink” effect can also compromise the efficacy of HIFU ablation. These 
results help derive the temperature dosage information that is necessary for 
achieving irreversible EP changes during HIFU ablation and also point out the 
importance of temperature monitoring during HIFU ablation. Further efforts are 
needed to develop robust temperature monitoring scheme to improve the 
efficacy of HIFU ablation. Unfortunately, we did not develop specific HIFU 
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ablation sequences (e.g. intensity values, pulse duration, duty cycle, and etc.) to 
achieve permanent EP damage and tissue lesioning. 
Finally, we developed ultrasound parametric imaging technique to 
monitor HIFU ablation in terms of tissue physical and action potential changes in 
CHAPTER 4. The specific imaging scheme is able to provide feedbacks along the 
ablation axial direction in the subsurface tissue layers, thereby, becoming a 
promising technique to monitor the lesion transmurality, which is critically 
important in ablation of AF. One advantage of the proposed imaging technique 
is its ability to identify the tissue area susceptible for electrical reconduction 
which is a major cause of recurrence of AF. However, implementation of the 
parametric imaging technique in real time at lower ultrasound imaging 
frequencies that is more appropriate in clinical needs to be tested in future. 
 
5.2 Future Works 
5.2.1 In-vivo Implementation of Ultrasound Imaging Technique 
In the dissertation (CHAPTER 4), we demonstrated using parametric 
ultrasound imaging to monitor HIFU generated lesion and EP changes. Real-time 
feedback during ablation (e.g. RF, HIFU) is imperative. Neven et al. have 
demonstrated PVI using HIFU could cause severe complications such as atrial-
esophageal fistula (AEF) which can be lethal.1,2 Esophageal temperature 
monitoring algorithm during HIFU ablation has been proved ineffective to avoid 
AEF.2 However, esophagus temperature monitoring combined with 





Figure 5.1 Anatomic relationship between the esophagus and left atrium. Major and 
subtypes of esophagus-posterior LA free wall relationship. (Left) SEM and masson’s 
trichrome stained esophagus-LA wall sagittal sections. (Right). Copyrights © American 
College of Chest Physicians4 and American Heart Association5. 
Figure 5.1 shows the anatomic relationship between an esophagus and 
posterior left atrium free wall. The distance between left atrium (the major target 
of PVI during catheter ablation) and esophageal wall appears to be around 10 
mm. In CHAPTER 4, we employed a 30 MHz ultrasound imaging probe with an 
imaging depth ~ 12.7 mm. Thereby, it is feasible to implement the parametric 
ultrasound imaging technique in in vivo circumstances to monitor RF or HIFU 
generated lesion in real time. By combining with ultrasound thermography or 
gas body detection algorithm6,7, the ablation process can be well monitored and 
the risks of AEF will be significantly lowered. If the trans-esophageal route was 
adopted, imaging-ablation sequences must be precisely synchronized to reduce 
detection error. Since current trans-esophageal echocardiography (TEE) system 
typically uses imaging frequency between 3.5 – 7 MHz, the detection accuracy 
using the proposed image algorithm may be compromised due to lowered 
imaging frequency. However, because single lesions with diameters within 5 – 10 
mm are typically used in clinical setting, it may be possible to detect lesion at 
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lower frequency without significant loss of detection accuracy. Further 
investigations are needed to explore the relationship between imaging frequency 
and the accuracy of lesion detection algorithm. 
Since current minimal invasive ablation techniques are mostly catheter 
based, another more promising method is the catheter-based ultrasound imaging 
system similar to the settings proposed by Wright et al8. High imaging frequency 
(e.g. > 30 MHz), which provide better imaging resolution, can be achieved. In 
addition to lesion detection, ultrasound imaging can be used for temperature 
estimation. Therefore, simultaneously two dimensional temperature monitoring 
and assessment of lesion transmurality can be realized in real time during 
ablation procedure, particularly for ablation of scar-related ventricular 
tachycardia or atrial tachycardia originating from relatively thick portions of the 
left atrium. Further efforts are needed to fabricate ultrasound imaging 
transducers compatible with current ablation energies such RF, microwave, laser, 
and HIFU to be able to provide accurate imaging feedback about lesion 
transmurality and to avoid overheating related complications such as perforation 
and esophagus injury. For such system, ECG or respiratory gated algorithm is 
necessary to reduce motion related false detection. 
5.2.2 Effect of Ultrasound Radiation Force on Cellular EP 
In CHAPTER 1, we have learnt two different ultrasonic effects can be used 
for therapeutic purposes: thermal effect (ablation) and mechanical effect (acoustic 
cavitation). Another interesting effect of ultrasound is radiation force, a type of 
ultrasound mechanical effect which is the net force exerted on tissue and shows 
the ability to displace the tissue away from its steady state position. It has been 
employed for remote tissue compression in acoustic elasticity imaging (e.g. 
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acoustic radiation force impulse [ARFI] imaging).9,10 Dalecki et al. did several 
pioneer works regarding the ultrasound induced premature ventricular 
contractions (PVC).11-13 Pulsed ultrasound energy was applied on murine hearts 
and the major effect for generating PVC was found to be acoustic radiation 
force.14 However, the detailed electrophysiological mechanism of ultrasound 
induced PVC is still unclear. Using the combined ultrasound and optical 
mapping system described in CHAPTER 2, we can investigate ultrasound 
radiation force generated cardiac EP changes spatiotemporally in real time in 2D. 
5.2.3 Sonoporation and Cardiac EP Responses 
Microbubbles under the excitation of ultrasound waves can generate 
transient pores on the membrane of adjacent cells, and this is defined as 
sonoporation. Research has demonstrated calcium influx was generated when 
cell membrane was sonoporated by ultrasound.15 For cardiac cells, calcium 
channel kinetics play a critical role in regulating membrane potentials. 
Specifically, L-type Ca2+ channels were proved to affect cardiac action potential 
plateau phase.16 Theoretically, by sonoporating the cell membrane, calcium influx 
can be generated, leading to changes of cellular membrane potentials. If periodic 
ultrasound exposure was generated, the rhythm of cardiomyocytes excitation 
can be potentially “controlled”. Using ultrasound contrast agent during 
echocardiography, premature ventricular arrhythmias (PVA) were observed 
when the microbubbles were excited by ultrasound energy.17-19 Therefore, we can 
use optical mapping technique to monitor sonoporation generated cardiac EP 
changes in a whole heart model. The mechanism of sonoporation related PVA 
can be revealed using proposed method in CHAPTER 2. Furthermore, using 
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periodic ultrasound exposures, cardiac arrhythmias can be potentially corrected 
using a sonoporation-based method. 
 
5.3 References 
1. Neven K, Metzner A, Schmidt B, Ouyang F, Kuck KH. Two-year clinical 
follow-up after pulmonary vein isolation using high-intensity focused 
ultrasound (hifu) and an esophageal temperature-guided safety algorithm. 
Heart Rhythm. 2012;9:407-413 
2. Neven K, Schmidt B, Metzner A, Otomo K, Nuyens D, et al. Fatal end of a 
safety algorithm for pulmonary vein isolation with use of high-intensity 
focused ultrasound. Circ Arrhythm Electrophysiol. 2010;3:260-265 
3. Mackensen GB, Hegland D, Rivera D, Adams DB, Bahnson TD. Real-time 3-
dimensional transesophageal echocardiography during left atrial 
radiofrequency catheter ablation for atrial fibrillation. Circ Cardiovasc 
Imaging. 2008;1:85-86 
4. Tsao HM, Wu MH, Higa S, Lee KT, Tai CT, et al. Anatomic relationship of the 
esophagus and left atrium: Implication for catheter ablation of atrial 
fibrillation. Chest. 2005;128:2581-2587 
5. Sanchez-Quintana D, Cabrera JA, Climent V, Farre J, Mendonca MC, Ho SY. 
Anatomic relations between the esophagus and left atrium and relevance for 
ablation of atrial fibrillation. Circulation. 2005;112:1400-1405 
6. Gudur MS, Kumon RE, Zhou Y, Deng CX. High-frequency rapid b-mode 
ultrasound imaging for real-time monitoring of lesion formation and gas 
body activity during high-intensity focused ultrasound ablation. IEEE Trans 
Ultrason Ferroelectr Freq Control. 2012;59:1687-1699 
7. Liu D, Ebbini ES. Real-time 2-d temperature imaging using ultrasound. IEEE 
Trans Biomed Eng. 2010;57:12-16 
8. Wright M, Harks E, Deladi S, Suijver F, Barley M, et al. Real-time lesion 
assessment using a novel combined ultrasound and radiofrequency ablation 
catheter. Heart Rhythm. 2011;8:304-312 
110 
 
9. Dalecki D. Mechanical bioeffects of ultrasound. Annu Rev Biomed Eng. 
2004;6:229-248 
10. Eyerly SA, Bahnson TD, Koontz JI, Bradway DP, Dumont DM, et al. 
Intracardiac acoustic radiation force impulse imaging: A novel imaging 
method for intraprocedural evaluation of radiofrequency ablation lesions. 
Heart Rhythm. 2012;9:1855-1862 
11. Dalecki D, Keller BB, Carstensen EL, Neel DS, Palladino JL, Noordergraaf A. 
Thresholds for premature ventricular contractions in frog hearts exposed to 
lithotripter fields. Ultrasound Med Biol. 1991;17:341-346 
12. Dalecki D, Raeman CH, Carstensen EL. Effects of pulsed ultrasound on the 
frog heart: Ii. An investigation of heating as a potential mechanism. 
Ultrasound Med Biol. 1993;19:391-398 
13. Dalecki D, Keller BB, Raeman CH, Carstensen EL. Effects of pulsed 
ultrasound on the frog heart: I. Thresholds for changes in cardiac rhythm and 
aortic pressure. Ultrasound Med Biol. 1993;19:385-390 
14. Dalecki D, Raeman CH, Child SZ, Carstensen EL. Effects of pulsed 
ultrasound on the frog heart: Iii. The radiation force mechanism. Ultrasound 
Med Biol. 1997;23:275-285 
15. Fan Z, Kumon RE, Park J, Deng CX. Intracellular delivery and calcium 
transients generated in sonoporation facilitated by microbubbles. J Control 
Release. 2010;142:31-39 
16. Lopez-Lopez JR, Shacklock PS, Balke CW, Wier WG. Local calcium transients 
triggered by single l-type calcium channel currents in cardiac cells. Science. 
1995;268:1042-1045 
17. Miller DL, Dou C, Lucchesi BR. Are ecg premature complexes induced by 
ultrasonic cavitation electrophysiological responses to irreversible 
cardiomyocyte injury? Ultrasound Med Biol. 2011;37:312-320 
18. Miller DL, Dou C, Lucchesi BR. Cardiac arrhythmia and injury induced in 
rats by burst and pulsed mode ultrasound with a gas body contrast agent. J 
Ultrasound Med. 2009;28:1519-1526 
19. Miller DL, Li P, Dou C, Armstrong WF, Gordon D. Evans blue staining of 
cardiomyocytes induced by myocardial contrast echocardiography in rats: 
111 
 








Langendorff Rabbit Experimental Procedural 
Preparation of Experiment 
1. Prepare Tyrode’s solution as described in the recipe. Stock solution can be 
stored in 4 °C refrigerator to avoid repetitive preparation before each 
experiment. 
2. After preparation of Tyrode’s solution, add in excitation-contraction decoupler 
15 mM BDM (~3 g) in every 2 L Tyrode’s solution for the perfusion and 
superfusion circulation. Prepare VSD di-4-ANEPPS stock solution (5 mg 
dissolved in 5 ml DMSO). Single rabbit heart typically require three 2L 
Tyrode’s solution (2 for perfusion and superfusion, 1 for dissection process) 
and roughly 30 μL di-4-ANEPPS stock solution. 
3. Prepare circulation stages and monitoring equipment. Warm up all Tyrode’s 
solutions at 37 °C via water bath and connect the container to the Langendorff 
circulation system. Oxygenate the Tyrode’s solution (95 % O2/5 % CO2) and 
keep monitoring the pH value. The pH value can be adjusted through 
adjustment of the speed of oxygenation (increase O2 tends to lower the pH) 
and keep pH value close to 7.35. Begin the circulation and the solution is 
filtered through a nylon net filter (NY1104700, EMD Millipore, Billerica, MA, 
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USA) and set up monitoring equipment (pressure monitoring, ECG 
monitoring). 
Rabbit Heart Harvesting 
1. Before harvesting the heart, transfer rough 250 ml warmed and oxygenated 
Tyrode’s solution into a small container. Add 0.2 ~ 0.5 ml Heparin solution in 
the container, which will be used for transporting the heart from surgery stage 
to the Langendorff system. 
2. The anesthesia and euthanasia procedure follows a protocol approved by 
UCUCA at University of Michigan. First anesthetize the rabbit through 
intramuscular injection of 0.7 ml Xylazine and 0.5 ml Ketamine. The rabbit will 
be anesthetized after 2 – 3 mins. Catheterize the marginal ear vein and inject 1 
ml Heparin (1000 U/kg). Two minutes later, inject 1 ml sodium pentobarbital 
(100 mg/kg) for euthanasia. The rabbit is euthanized immediately which can 
be confirmed through pain reflex test. Median sternotomy is performed 
immediately and the heart is excised and kept in the transportation Tyrode’s 
solution. 
3. Quickly cut the aorta along ascending direction right before the first branch of 
aortic arch. Immediately cannulate the heart using a 16-gauge cannula which 
is connected to a bubble trapper. Tight the heart with the cannula using suture 
and start perfusion of a non-recirculating Langendorff system (dissection 
stage) while keep aortic pressure at 60 – 80 mmHg. 
4. Open the pericardium quickly to avoid cardiac tamponade. Cut off the 
peripheral tissue (e.g. lungs, fat, thyroid, and trachea). Cut open the 
pulmonary artery which is close to the aorta. 
114 
 
5. Blood trapped in the heart is flushed out. Move the heart to the recirculating 
Langendorff system by connecting cannula to perfusion inlet and prepare for 
HIFU ablation and optical mapping. Adjust the pump speed to keep the aortic 
pressure stable (60 – 80 mmHg). Place the floating ECG needle electrodes to 
mimic the Lead I and II of the Einthoven triangle ECG. 
Focusing HIFU Transducer 
1. Move the heart holder such that the intact rabbit heart is in the middle of the 
tissue chamber. Rotate the heart to let the desired ablation region face the 
HIFU transducer and wait the heart to stabilize. 
2. Connect the HIFU transducer with an electrical pulser-receiver which is 
connected to an oscilloscope. Turn on the pulser-receiver and monitor the 
signal from the oscilloscope. 
3. A pulse signal is sent out by HIFU transducer. Once the single pulse propagate 
across different mediums (e.g. tissue water), portion of the acoustic energy is 
reflected due to the impedance difference between mediums. The reflecting 
echo is captured by HIFU transducer and displayed on the oscilloscope. The 
time of flight between pulse and echo is used to estimate the distance between 
HIFU transducer and the target. 
4. Adjust the position of HIFU transducer using pulse-echo method and move 
the HIFU focus on to the desired target (LV or RV) by comparing the time-of-
flight with the calibrated HIFU focal length. 
5. Fix both heart and HIFU transducer and set up HIFU ablation parameters 
through function generator and FPGA board. 
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Optical Mapping Procedure 
1. Turn off the room light and slowly inject 20 μL di-4-ANEPPS solution into the 
perfusate. Wait roughly 10 mins for the VSD to load in before taking optical 
maps. 
2. Turn on the LED excitation lights in a flashing mode (100 ms flash) and adjust 
the focus of the camera and check the signal quality from optical mapping. 
Adjust the excitation light intensities to the 80 % of the saturation intensity 
over 2 – 3 s test. 
3. Set up the optical mapping parameters (frame rate, duration, triggering, and 
continuous excitation) and start designed experiment. During 
experimentation, if the signal-noise ratio is low due to photobleaching and 
wash out, add another 5 – 10 μ di-4-ANEPPS solution. 
4. After finishing all the experiment, remove the heart from the cannula and 
perform TTC staining and leave it in 10 % formalin solution for further 
histological staining. Turn off the oxygen. Drain all the circulating solutions 
and wash the Langendorff system and tissue chamber by perfusing 70 % 
isopropyl alcohol, distilled water, and air in order. 
5. Finally, clean up all the equipment and surgical tools and export data from 
optical mapping system for further analysis. 
 
Preparation of Tyrode’s Solution 
A recipe of Tyrode’s solution is shown in Table A1. Tyrode’s solution for 
rabbit heart is prepared following a protocol described as following. 
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Table A1. Recipe of Tyrode’s stock solution. 
    Stock I Stock II  
 mM MW g/L 25X g/2L 25X g/2L g/2L 
NaCl 128.2 58.44 7.49 374.60   
CaCl2∙2H2O 1.3 147.02 0.19 9.56   
KCl 4.7 74.56 0.35 17.52   
MgCl2∙6H2O 1.05 203.31 0.21 10.67   
NaH2PO4 1.19 137.99 0.16 8.21   
NaHCO3 20 84.01 1.68  84.01  
Glucose 11.1 180.16 2.00   4.0 
 
First, prepare two 2L bottles of Stock I solution and Stock II, which can be 
stored in the refrigerator. Then put 80 ml of Stock I solution in 2L volumetric 
flask. Add 1 L of distilled water (otherwise Stock I and Stock II solution will react 
and precipitate). Then add 80 ml of Stock II solution in the flask. Weight 4 g of 
glucose (dextrose) and add into the flask. Add distilled water to reach 2 L mark 
on the flask. Completely dissolve the glucose using magnetic stirrer. 
Preparation of Cardioplegia Solution 
St. Thomas No.2 solution is used as cardioplegic solution. The 
cardioplegia needs to be prepared no more than 2 hours before experimentation. 
The recipe of St. Thomas No.2 is shown as Table A2. 
Table A2. Recipe of St. Thomas No.2 cardioplegia solution. 
Ingredients NaCl KCl CaCl2∙2H2O NaHCO3 MgCl2∙6H2O 
mmol/L 100 16 1.2 10 16 
g/L 5.85 1.19 0.18 0.84 3.25 
Quantity in 2L 
solutions (g) 




The procedure of preparing cardioplegic solution is described as 
following. First weight the ingredients in Table A2 and add into 2L beaker. Then 
add distilled water to reach the 2L mark on the beaker. Then adjust the 
osmolarity to 285 ~ 300 mosm/KgH2O with glucose and osmometer (roughly 4g 
glucose in 2L solution). Dilute all the ingredients using magnetic stirrer. 
Transport the solution to the flask, seal the flask, and store in the refrigerator. 
Before use, adjust the pH value to 7.8 with O2/CO2 (95 %/5 %). 
TTC Staining Procedure 
TTC stock solutions are prepared using the recipe in Table A3. Mix the 
two different solutions with a volumetric ratio of 2:1. Use Na2HPO4 solution to 
adjust the pH value to be 7.4. First pull 40 ml stock solution in a container and 
add 400 mg TTC powder. Mix the solution with power completely. Warm up the 
stock solution before tissue staining process. Put the tissue in the container and 
keep the container in a warm waterbath for 20 mins. Take out the tissue and take 
pictures. (Do not leave the tissue in the TTC solution for more than 25 mins. 
Tissue volume will shrink.) 
Table A3. Recipe of stock solutions for TTC staining. 
Na2HPO4 NaH2PO4 
1 L – 14.2 g 0.5 L – 6 g 
 
